<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4671598</article-id><article-id pub-id-type="pmid">26642319</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0144025</article-id><article-id pub-id-type="publisher-id">PONE-D-15-29362</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Overexpression of Catalase Diminishes Oxidative Cysteine Modifications of Cardiac Proteins</article-title><alt-title alt-title-type="running-head">Reversible Cysteine Oxidation in Cardiac Disease and Aging</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yao</surname><given-names>Chunxiang</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Behring</surname><given-names>Jessica B.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Shao</surname><given-names>Di</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sverdlov</surname><given-names>Aaron L.</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Whelan</surname><given-names>Stephen A.</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Elezaby</surname><given-names>Aly</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Yin</surname><given-names>Xiaoyan</given-names></name><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref><xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Siwik</surname><given-names>Deborah A.</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Seta</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Costello</surname><given-names>Catherine E.</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cohen</surname><given-names>Richard A.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Matsui</surname><given-names>Reiko</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Colucci</surname><given-names>Wilson S.</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>McComb</surname><given-names>Mark E.</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Bachschmid</surname><given-names>Markus M.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001">
<label>1</label>
<addr-line>Vascular Biology Section, Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, United States of America</addr-line>
</aff><aff id="aff002">
<label>2</label>
<addr-line>Myocardial Biology Unit, Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, United States of America</addr-line>
</aff><aff id="aff003">
<label>3</label>
<addr-line>Cardiovascular Proteomics Center, Center for Biomedical Mass Spectrometry, Boston University School of Medicine, Boston, Massachusetts, United States of America</addr-line>
</aff><aff id="aff004">
<label>4</label>
<addr-line>Boston University and National Heart, Lung and Blood Institute&#8217;s Framingham Heart Study, Framingham, Massachusetts, United States of America</addr-line>
</aff><aff id="aff005">
<label>5</label>
<addr-line>Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Franco</surname><given-names>Rodrigo</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Nebraska-Lincoln, UNITED STATES</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: CY JBB ALS SAW RAC MEM MMB. Performed the experiments: CY JBB DS ALS SAW AE DAS. Analyzed the data: CY JBB ALS XY MEM MMB. Contributed reagents/materials/analysis tools: XY DAS FS CEC WSC RAC MEM. Wrote the paper: CY JBB FS CEC WSC RAC RM MEM MMB.</p></fn><corresp id="cor001">* E-mail: <email>bach@bu.edu</email> (MMB); <email>mccomb@bu.edu</email> (MEM)</corresp></author-notes><pub-date pub-type="epub"><day>7</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>12</issue><elocation-id>e0144025</elocation-id><history><date date-type="received"><day>4</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>26</day><month>10</month><year>2015</year></date></history><permissions><copyright-statement>&#169; 2015 Yao et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Yao et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0144025.pdf"/><abstract><p>Reactive protein cysteine thiolates are instrumental in redox regulation. Oxidants, such as hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), react with thiolates to form oxidative post-translational modifications, enabling physiological redox signaling. Cardiac disease and aging are associated with oxidative stress which can impair redox signaling by altering essential cysteine thiolates. We previously found that cardiac-specific overexpression of catalase (Cat), an enzyme that detoxifies excess H<sub>2</sub>O<sub>2</sub>, protected from oxidative stress and delayed cardiac aging in mice. Using redox proteomics and systems biology, we sought to identify the cysteines that could play a key role in cardiac disease and aging. With a &#8216;Tandem Mass Tag&#8217; (TMT) labeling strategy and mass spectrometry, we investigated differential reversible cysteine oxidation in the cardiac proteome of wild type and Cat transgenic (Tg) mice. Reversible cysteine oxidation was measured as thiol occupancy, the ratio of total available versus reversibly oxidized cysteine thiols. Catalase overexpression globally decreased thiol occupancy by &#8805;1.3 fold in 82 proteins, including numerous mitochondrial and contractile proteins. Systems biology analysis assigned the majority of proteins with differentially modified thiols in Cat Tg mice to pathways of aging and cardiac disease, including cellular stress response, proteostasis, and apoptosis. In addition, Cat Tg mice exhibited diminished protein glutathione adducts and decreased H<sub>2</sub>O<sub>2</sub> production from mitochondrial complex I and II, suggesting improved function of cardiac mitochondria. In conclusion, our data suggest that catalase may alleviate cardiac disease and aging by moderating global protein cysteine thiol oxidation.</p></abstract><funding-group><funding-statement>This work was supported by the NHLBI, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN268201000031C, and by NIH grants P01 HL 068758, R37 HL104017, R01 HL064750, R01 HL031607, P41 GM104603, R01 DK103750 and S10 OD010724. ALS is funded by a CJ Martin Fellowship from the National Health and Medical Research Council of Australia (APP1037603), the Marjorie Hooper Overseas Fellowship from the Royal Australasian College of Physicians and AHA Postdoctoral Fellowship 14POST20490003. DS is funded from the AHA Postdoctoral Fellowship 15POST21790006. The contents are solely the responsibility of the authors and do not represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="0"/><page-count count="20"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>Data are available via ProteomeXchange with identifier PXD002479.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>Data are available via ProteomeXchange with identifier PXD002479.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Excessive oxidant formation is associated with cardiac disease and aging [<xref rid="pone.0144025.ref001" ref-type="bibr">1</xref>]. In an attempt to ameliorate cardiac diseases and delay aging by decreasing oxidative stress, mouse models overexpressing cellular antioxidant enzymes, including catalase, were created. Catalase detoxifies the intracellular oxidant hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) [<xref rid="pone.0144025.ref002" ref-type="bibr">2</xref>]. We and others have previously shown that cardiac-specific catalase overexpression in transgenic mice (Cat Tg) prevents oxidative stress, preserves diastolic heart function and delays cardiac aging [<xref rid="pone.0144025.ref003" ref-type="bibr">3</xref>&#8211;<xref rid="pone.0144025.ref005" ref-type="bibr">5</xref>]. In addition, Cat Tg mice are also protected from doxorubicin toxicity [<xref rid="pone.0144025.ref006" ref-type="bibr">6</xref>], ischemia-reperfusion injury [<xref rid="pone.0144025.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0144025.ref008" ref-type="bibr">8</xref>], inflammation [<xref rid="pone.0144025.ref009" ref-type="bibr">9</xref>], and overt heart failure [<xref rid="pone.0144025.ref010" ref-type="bibr">10</xref>].</p><p>H<sub>2</sub>O<sub>2</sub> can have dual effects; acting at physiological levels as an essential signaling molecule or in excess as a damaging oxidant [<xref rid="pone.0144025.ref011" ref-type="bibr">11</xref>]. Protein cysteine thiolates (Cys-S<sup>-</sup>), as compared to thiols (Cys-SH), are chemically reactive and confer redox sensitivity. These thiolates or &#8220;redox sensors&#8221; can react with H<sub>2</sub>O<sub>2</sub> to form a labile sulfenic acid (S-OH) intermediate, which quickly reacts with the abundant intracellular low-mass thiol glutathione (GSH). The resulting protein GSH-adduct is a reversible oxidative protein modification that participates in cellular redox signaling and regulates protein activity, interaction, localization, and stability [<xref rid="pone.0144025.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0144025.ref012" ref-type="bibr">12</xref>]. Redox signaling, however, becomes dysregulated or impaired when oxidants are generated in excess, and this leads to oxidative stress and irreversible modifications as observed in cardiac disease and aging.</p><p>We studied reversible protein cysteine thiol oxidation in heart lysates from adult wild type and Cat Tg mice. Iodoacetyl &#8216;Tandem Mass Tags&#8217; (iodoTMT) developed for multiplexed quantitative mass spectrometry were used in an approach similar to established biotin-switch assays to label and analyze oxidation of protein cysteine thiols [<xref rid="pone.0144025.ref013" ref-type="bibr">13</xref>]. Using this labeling strategy in combination with proteomics mass spectrometry, we determined the ratio of reversibly oxidized cysteine thiols to total available cysteines&#8212;referred to as thiol occupancy&#8212;on a site-specific basis for wild type and Cat Tg mice. Significant differences in thiol occupancy for Cat Tg and WT mice identify the most reactive and, therefore, potential functionally relevant cysteines in proteins. We aimed to provide evidence that by overexpressing catalase, reactive cysteine thiols are maintained in a functional state and protected from the irreversible oxidation observed in cardiac disease and aging. Our results provide novel insights into catalase function that, beyond ameliorating oxidative stress, may also influence protective cellular signaling pathways.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and Methods</title><sec id="sec003"><title>Experimental animals and materials</title><p>Male and female FVB/N mice (N = 5 per group) with cardiac-specific catalase overexpression and wild type controls were used. The protocol was approved by the Institutional Animal Care and Use Committee at Boston University School of Medicine. Mice were euthanized at 10 months of age and hearts were perfused to remove blood proteins, excised, snap frozen, and stored in liquid nitrogen or at -80&#176;C. All materials were purchased from Thermo Fisher Scientific (Waltham, MA, USA) unless otherwise specified.</p></sec><sec id="sec004"><title>Mitochondrial isolation</title><p>Heart mitochondria were isolated as we have described previously, with minor modifications [<xref rid="pone.0144025.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0144025.ref015" ref-type="bibr">15</xref>]. All steps were performed on ice. Briefly, tissues were rinsed in a buffer containing 100 mM KCl, 5 mM EGTA and 5 mM HEPES pH 7.4, and thereafter homogenized in 2 ml of HES buffer (HEPES 5 mM, EDTA 1 mM, sucrose 0.25 M, pH 7.4 adjusted with KOH 1 M) using a Teflon-on-glass electric homogenizer. The homogenate was centrifuged at 500 &#215; <italic>g</italic> for 10 min at 4&#176;C. The supernatant was then centrifuged at 9000 &#215; <italic>g</italic> for 15 min at 4&#176;C and the mitochondrial pellet was re-suspended in 100 &#956;l of HES buffer with 0.3% of fatty acid-free bovine serum albumin. Protein was quantified using the BCA assay (Pierce) and the value of HES-BSA buffer alone was subtracted.</p></sec><sec id="sec005"><title>H<sub>2</sub>O<sub>2</sub> production in isolated mitochondria</title><p>Mitochondrial H<sub>2</sub>O<sub>2</sub> production in isolated cardiac mitochondria was measured using the Amplex Ultra Red-Horseradish peroxidase method (Invitrogen) as we described previously, with minor modifications [<xref rid="pone.0144025.ref015" ref-type="bibr">15</xref>]. This assay is based on the Horseradish peroxidase (2 units/ml) H<sub>2</sub>O<sub>2</sub>-dependent oxidation of non-fluorescent Amplex Ultra Red (50 &#956;M) to fluorescent resorufin red. In short, 10 &#956;g mitochondria were diluted in 50 &#956;l reaction buffer (125 mM KCl, 10 mM HEPES, 5 mM MgCl<sub>2</sub>, 2 mM K<sub>2</sub>HPO<sub>4</sub>, pH 7.44) to determine complex I- (pyruvate/ malate, 5 mM) or complex II- (succinate, 5 mM; with and without inhibitor, rotenone 2 &#956;M) driven H<sub>2</sub>O<sub>2</sub> production. Mitochondrial H<sub>2</sub>O<sub>2</sub> production was measured after the addition of 50 &#956;l of reaction buffer containing horseradish peroxidase and Amplex Ultra Red. Fluorescence was followed at an excitation wavelength of 545 nm and an emission wavelength of 590 nm for 20 min. The slope of the increase in fluorescence is converted to the rate of H<sub>2</sub>O<sub>2</sub> production with a standard curve. All of the assays were performed at 25&#176;C. The results are reported as pmoles/min/mg protein.</p></sec><sec id="sec006"><title>ATP production in isolated mitochondria</title><p>ATP synthesis rates in isolated heart mitochondria were determined using the luciferin/luciferase based ATP Bioluminescence Assay Kit CLS II (Roche) as we have previously described, with minor modifications [<xref rid="pone.0144025.ref015" ref-type="bibr">15</xref>]. In short, 10 &#956;g of heart mitochondria were suspended in 75 &#956;l buffer A (125 mM KCl, 10 mM HEPES, 5 mM MgCl<sub>2</sub> and 2 mM K<sub>2</sub>HPO<sub>4</sub>, pH7.44) to determine complex I- (pyruvate/ malate, 5 mM final) or complex II- (succinate, 5 mM final) driven ATP synthesis. Following standard practice, succinate-driven ATP generation was measured in the presence of complex I inhibitor rotenone (2 &#956;M) to avoid the reverse electron transfer effect [<xref rid="pone.0144025.ref016" ref-type="bibr">16</xref>]. Measurements with substrates were repeated in the presence of oligomycin to determine the rates of non-mitochondrial ATP production. The background of the assay was determined with mitochondria alone. The measurements for all samples were started simultaneously by adding 75 &#956;l of luciferin/luciferase buffer containing 1 mM ADP (0.5 mM final). The initial slope of the increase in ATP-supported luciferase chemiluminescence was used to determine the rate of ATP production after subtraction of the background and non-mitochondrial values. Using an ATP standard provided in the kit, the slopes were converted to nmoles/min/mg protein.</p></sec><sec id="sec007"><title>Oxygen consumption rate in isolated mitochondria</title><p>Oxygen consumption rates were monitored using a Seahorse XF24 oxygen flux analyzer, as previously described by our group [<xref rid="pone.0144025.ref014" ref-type="bibr">14</xref>]. Isolated mitochondria were loaded in a 24-well Seahorse plate on ice (5&#8211;12.5 &#956;g per well) and 500 &#956;l of ice-cold mitochondrial assay solution (MAS: 70 mM sucrose, 220 mM mannitol, 5 mM KH<sub>2</sub>PO<sub>4</sub>, 5 mM MgCl<sub>2</sub>, 2 mM HEPES, 1 mM EGTA, 0.3% BSA fatty acid-free, pH 7.4) were added on top. The 4 sequential injection ports of the Seahorse cartridge contained the following: Port A- 50 &#956;l of 10X substrate (complex I: 50 mM pyruvate and 50 mM malate; complex II: 50 mM succinate and 20 &#956;M rotenone in MAS) and 2.5 mM ADP, Port B- 55 &#956;l of 20 &#956;M oligomycin, Port C- 60 &#956;l of 40 &#956;M FCCP, Port D- 65 &#956;l of 40 &#956;M antimycin A. State III was determined after port A injection, state IV after port B, and uncoupled after port C. Antimycin A was used as a control because it blocks the electron transport chain to minimize mitochondrial oxygen consumption. The results are reported as &#961;mol oxygen/min/&#956;g protein.</p></sec><sec id="sec008"><title>Immunoblotting</title><p>Hearts were lysed in RIPA buffer (50mM Tis-HCl, pH 7.2, 0.15 M NaCl, 1.0 mM EDTA, 0.1% SDS, 1.0% Triton X-100, 1.0% sodium deoxycholate). Tissue lysates were separated on non-reducing SDS-polyacrylamide gels and transferred to polyvinylidene fluoride membranes (Immobilon, Millipore), blocked in 5% nonfat milk, and incubated overnight with the anti-GSH antibody (Virogen, 101-A). Subsequently, blots were incubated with IR dye-conjugated secondary antibodies and visualized using the LI-COR Odyssey system. Band intensities were measured using ImageJ, and values were normalized to GAPDH as a loading control.</p></sec><sec id="sec009"><title>Homogenization and protein extraction from heart tissue for mass spectrometry analysis</title><p>The left heart ventricle was divided into two pieces; homogenization and extraction of individual pieces were carried out in lysis buffer containing 50 mM Tris pH 7.4, 150 mM NaCl 0.5 mM diethylene triamine pentaacetic acid (DTPA) (Sigma, St. Louis, MO) and protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN) (1 tablet/10 ml of lysis buffer) supplemented with either 10 mM iodoacetamide (Sigma) to block free thiols or 1 mM tris(2-carboxyethyl)phosphine (TCEP, Thermo Fisher Scientific) to completely reduce all reducible thiols. LVs were homogenized for two cycles of 54 sec in a gentleMACS Dissociator (MACS Miltenyl Biotec, Cologne, Germany). Mass spectrometry compatible RapiGest SF surfactant (0.1%, v/v, Waters, Milford, MA) was subsequently introduced into the lysis mixture to avoid foaming during homogenization. Lysates were rotated for 2 h at 4&#176;C, aliquotted, and frozen at -80&#176;C. The protein concentration for each sample was determined using the colorimetric Bio-Rad detergent-compatible protein assay (BioRad, Hercules, CA) and by Imperial staining (Thermo Fisher Scientific) of sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE).</p></sec><sec id="sec010"><title>iodoTMT-labelling and enrichment</title><p>One hundred &#956;g of each protein lysate was used to label the reversibly oxidized thiols or total available (all reducible) thiols, from either control or Cat Tg LV homogenates. Then 7-kDa MWCO Zeba spin columns (Pierce, Thermo Scientific) equilibrated with Tris-buffered saline (TBS: 25mM Tris and 0.15 M NaCl, pH 7.2&#8211;7.5) containing 5% acetonitrile (ACN) and 0.005% ProteaseMAX (Promega, Madison, WI) were used to remove excess IAM from blocked samples before 45 min of reduction with TCEP at 37 <sup>o</sup>C. Completely reduced samples were thawed and passed through 7kDa MWCO Zeba columns pretreated with TCEP-containing buffer, and incubated to maintain conditions similar to blocked samples. Next, each sample was tagged with a different isobaric iodoacetyl Tandem Mass Tag&#8482; (iodoTMT&#8482;) reagent (Thermo Scientific) at 1 mM for 2 h at room temperature. Samples representing all four conditions were combined, then precipitated with acetone containing 0.1% acetic acid at -20&#176;C overnight. Protein pellets were washed with ice-cold acetone, and then resuspended in 1x Tris supplemented with 0.05% ProteaseMAX and 5% ACN. Proteins were digested with trypsin (1:20 enzyme-to-protein ratio) overnight at 37&#176;C. Immobilized anti-TMT resin was used to immunoprecipitate (IP) TMT-tagged peptides at a 1 &#956;g protein/1 &#956;l resin ratio overnight at 4&#176;C. Resin was washed three times with TBS, three times with 4 M urea, and four times with water. The TMT-tagged peptides were eluted with TMT-elution buffer (Thermo Scientific) and concentrated in a vacuum concentrator at 4&#176;C. Peptides were dissolved in 0.1% formic acid (FA) in 2% ACN and desalted with C18 spin columns (NestGroup). Peptides were eluted from the C18 columns twice with 0.1% FA in 60% ACN. Samples were then dried using a SpeedVac&#8482; concentrator (Savant, Thermo Fisher Scientific) and reconstituted in 2% ACN with 0.1% FA. Preliminary MS analysis was performed with an UltrafleXtreme MALDI-TOF/TOF MS (Bruker Daltonics, Billerica, MA) using 2,5-dihydroxybensoic acid matrix, followed by analysis with the Q Exactive&#8482; mass spectrometer described below.</p></sec><sec id="sec011"><title>Liquid chromatography-tandem mass spectrometry (LC-MS/MS)</title><p>LC-MS/MS was performed on peptide samples using a nanoAcquity UPLC&#8482; nano-capillary high-performance LC system (Waters Corp., Milford, MA) coupled to a Q Exactive&#8482; hybrid quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific, San Jose, CA) equipped with a TriVersa NanoMate ion source (Advion, Ithaca, NY). Sample concentration and desalting were performed online using a nanoAcquity UPLC&#8482; trapping column (180 &#956;m x 20 mm, packed with 5 &#956;m, 100 &#197; Symmetry C18 material, Waters Corp.) at a flow rate of 15 &#956;l/min for 1 min. Separation was accomplished on a nanoAcquity UPLC&#8482; capillary column (150 &#956;m x 100 mm, packed with 1.7 &#956;m, 130 &#197; BEH C18 material, Waters Corp.). A linear gradient of A and B buffers (buffer A: 1.5% ACN/ 0.1% FA; buffer B: 98.5% ACN/ 0.1% FA) from 3% to 55% buffer B over 120 min was used at a flow rate of 0.5 &#956;l/min to elute peptides into the mass spectrometer. Columns were washed and re-equilibrated between LC-MS/MS experiments. Electrospray ionization was carried out at 1.65 kV using the NanoMate, with the Q Exactive heated transfer capillary set to 250&#176;C. Mass spectra were acquired in the positive-ion mode over the range <italic>m/z</italic> 400&#8211;2000 at a resolution of 70,000 (fwhm at <italic>m/z</italic> 400), target AGC values of 1E6, and maximum individual fill times of 200 ms. Mass accuracy after internal calibration was within 1 ppm. MS/MS spectra were acquired at a resolution of 17,500 (fwhm at <italic>m/z</italic> 100), target AGC values of 1E6, and isolation window of 3.0 <italic>m/z</italic>, using higher-energy collisional dissociation (HCD) with 30% MS/MS collision energies (NCE) and nitrogen as the collision gas. Maximum individual fill time was set as 60 ms for the 10 most abundant, multiply-charged species in each MS spectrum with signal intensities of &gt; 3.3E5. MS/MS spectra were acquired over an <italic>m/z</italic> range that depended on each precursor ion. Dynamic exclusion was set such that MS/MS for each species was excluded for 2 sec post-acquisition. All spectra were recorded in profile mode for further processing and analysis.</p></sec><sec id="sec012"><title>Data analysis</title><p>MS and MS/MS data analyses were carried out using Proteome Discoverer (PD) 1.4 (Thermo Fisher Scientific). For Protein/peptide identification, the MS/MS spectra were searched against the UniProtKB mouse protein database (20130107/83589 sequence entries) using the Sequest HT search engine. The search was conducted with the following constraints: full tryptic peptides with maximum four missed cleavage sites, precursor mass tolerance 10 ppm, and fragment ion mass error 0.02 Da. IodoTMT6plex-labeled (C), di- and tri-oxidized (C), carbamidomethyl (C), deamidation (NQ), and oxidation (M) were specified as dynamic modifications. False discovery rate (FDR) was determined through decoy database search using Percolator node for peptide-spectrum-match (PSM) validation. Peptides assignment with FDR&lt;1% were indicated as highly confident and selected for further analysis.</p><p>For relative quantification of TMT-labeled cysteines, reporter ions were specified with the integration tolerance of 20 ppm using most confident centroid method. Thermo lot-specific reporter ion correction factors were applied for &#8220;quan value&#8221; determination. Protein GO annotations and subcellular locations were derived from open source software STRAP (Cardiovascular Proteomics Center, Boston University School of Medicine, Boston, MA) [<xref rid="pone.0144025.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0144025.ref018" ref-type="bibr">18</xref>]. Peptide events without iodoTMT modification or without matched protein were excluded. For each MS/MS spectrum used for quantification, PD used the intensity of each reporter ion to calculate the following ratios between biological samples: 1) changes in total available cysteines and 2) changes in reversibly oxidized cysteine thiols. Only the median ratio was reported as the change for the assigned peptide. Thiol occupancy caused by reversible oxidation was calculated as the ratio of reversibly oxidized thiol to the total available thiols for the same peptide. These values were then compared between mice. TMT-tagged peptides having less than 35% coefficients of variation (CVs) among measured replicate mice, both for their change in total available cysteine and reversibly oxidized cysteines, were selected for further analysis. Fold changes between samples were expressed as log2 value of the ratios for all quantifiable peptides. The proteins exhibiting changes in reversible thiol oxidation (cutoff &#8805;1.3-fold change is common threshold for gene chip and RT-qPCR analysis) were analyzed for functional relevance using Ingenuity&#8482; Pathway Analysis (IPA) (IPA&#8482;, QIAGEN Redwood City, <ext-link ext-link-type="uri" xlink:href="http://www.qiagen.com/ingenuity">www.qiagen.com/ingenuity</ext-link>). Direct and indirect relationship data derived from all wild type and mutant cells and tissue from mouse, rat, and human were included. Endogenous chemicals were also included in the canonical pathway analysis.</p></sec></sec><sec id="sec013"><title>Results and Discussion</title><sec id="sec014"><title>Detection of reversible cysteine oxidation with TMT switch and mass spectrometry</title><p>Using our previously published iodoTMT switch assay and mass spectrometry [<xref rid="pone.0144025.ref013" ref-type="bibr">13</xref>] (<xref rid="pone.0144025.s001" ref-type="supplementary-material">S1 Fig</xref>), reversible protein cysteine thiol oxidation and total available cysteines were measured in left ventricles from wild type and Cat Tg mice (N = 5). In summary, 2125 TMT-tagged peptides were identified (<xref rid="pone.0144025.s005" ref-type="supplementary-material">S1 Table</xref>), which originated from 1017 proteins localizing to various subcellular compartments, including mitochondria (18%), cytoplasm (13%), nucleus (13%), plasma membrane (8%), cytoskeleton (6%) and peroxisome/microbodies (1%) (<xref rid="pone.0144025.g001" ref-type="fig">Fig 1</xref>).</p><fig id="pone.0144025.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0144025.g001</object-id><label>Fig 1</label><caption><title>Detection of reversible cysteine thiol oxidation with TMT switch and mass spectrometry.</title><p>Cellular compartment pie chart of 1017 proteins containing TMT-tagged cysteine thiols.</p></caption><graphic xlink:href="pone.0144025.g001"/></fig></sec><sec id="sec015"><title>Global changes in protein cysteine thiol oxidation associated with catalase overexpression</title><p>The global effects of catalase overexpression on total available (<xref rid="pone.0144025.g002" ref-type="fig">Fig 2A</xref>) and reversibly oxidized cysteine thiols (<xref rid="pone.0144025.g002" ref-type="fig">Fig 2B</xref>), as well as thiol occupancy (<xref rid="pone.0144025.g002" ref-type="fig">Fig 2C</xref>) was measured for 199 qualifying peptides (<xref rid="pone.0144025.s002" ref-type="supplementary-material">S2 Fig</xref>) from 147 proteins, which are depicted in a log2 transformed frequency histogram. Reversible cysteine thiol oxidation was significantly decreased in Cat Tg mice (a log2 transformed mean of -0.52 indicates a 1.4-fold decrease in Cat Tg <italic>vs</italic>. WT, <xref rid="pone.0144025.g002" ref-type="fig">Fig 2B</xref>). Calculating the ratio of reversibly oxidized to total available cysteine thiols enables quantification of changes in thiol occupancy, and can be used to differentiate regulatory cysteines in adult Cat Tg mice. The thiol occupancy (<xref rid="pone.0144025.g002" ref-type="fig">Fig 2C</xref>, a log2 transformed mean of -0.68 indicates a 1.6-fold decrease) was significantly decreased in Cat Tg mice and paralleled that of reversible cysteine thiol oxidation.</p><fig id="pone.0144025.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0144025.g002</object-id><label>Fig 2</label><caption><title>Global changes in cysteine oxidation associated with catalase overexpression.</title><p>Log2 transformed reporter ion rations from Cat Tg <italic>vs</italic>. WT mice were used to generate frequency histograms of TMT-tagged peptides. The ratios used are as follows: (A) changes in the total available cysteines; (B) changes in the reversibly oxidized cysteine thiols; (C) changes in the thiol occupancy of reversible oxidation (dashed line indicates no change with log2 ratio = 0).</p></caption><graphic xlink:href="pone.0144025.g002"/></fig><p>Because no experimental precautions were taken to preserve very labile and transient cysteine modifications, including <italic>S</italic>-nitrosylation and <italic>S</italic>-sulfenylation [<xref rid="pone.0144025.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0144025.ref020" ref-type="bibr">20</xref>], and owing to high intracellular glutathione levels [<xref rid="pone.0144025.ref021" ref-type="bibr">21</xref>], we deem that most of the thiol modifications are either protein GSH adducts or disulfides. However, the type of modification needs to be determined in future studies, on a case-by-case basis.</p><p>Overall, 17 proteins with increased total available cysteine thiols, and 82 proteins with decreased reversible cysteine thiol oxidation exhibited biologically significant changes in Cat Tg <italic>vs</italic>. WT mice. These proteins are involved in various cellular pathways that protect from oxidative and metabolic stress, protein misfolding and apoptosis. Proteins with a &#8805;2-fold change in thiol occupancy are summarized in <xref rid="pone.0144025.s006" ref-type="supplementary-material">S2 Table</xref>. Below, we speculate about and discuss the potential functional significance of thiol modifications of some of these proteins in the context of cardiac disease and aging.</p></sec><sec id="sec016"><title>Effects of overexpression on catalase itself and other antioxidant systems</title><p>We measured a 14-fold increase in total available cysteines for catalase (Cat, Q3UF58) from Cat Tg mice, clearly indicating catalase overexpression and thus, validating our proteomics approach. Moreover, the regulatory site of catalase activity (Cys376) [<xref rid="pone.0144025.ref022" ref-type="bibr">22</xref>], exhibited a 24.5-fold decrease in thiol occupancy.</p><p>Catalase is highly efficient in detoxifying large quantities of H<sub>2</sub>O<sub>2</sub> and preventing oxidative stress. These properties could protect other cellular antioxidants from oxidation and improve their effectiveness. Peroxiredoxins, which also decompose H<sub>2</sub>O<sub>2</sub>, are highly redox-sensitive proteins susceptible to irreversible oxidation [<xref rid="pone.0144025.ref023" ref-type="bibr">23</xref>,<xref rid="pone.0144025.ref024" ref-type="bibr">24</xref>]. Cys96, one of the two redox-active cysteines in peroxiredoxin 5, showed decreased cysteine thiol oxidation, which likely improves its activity (Prdx5, Q9JHL8, 1.2-fold decrease in thiol occupancy in Cat Tg <italic>vs</italic>. WT).</p><p>The redox-sensitive substrate binding sites of carbonyl reductase 1, an NADPH-dependent short chain dehydrogenase/reductase [<xref rid="pone.0144025.ref025" ref-type="bibr">25</xref>&#8211;<xref rid="pone.0144025.ref027" ref-type="bibr">27</xref>], also showed attenuated oxidation in Cat Tg mice (Cbr1, P48758, 3.0-fold decrease in thiol occupancy of Cys226 and Cys227 in Cat Tg <italic>vs</italic>. WT). Cbr1 has been linked to the detoxification of reactive aldehydes, such as the lipid peroxidation product 4-hydroxynonenal, under conditions of oxidative stress. Moreover, Cbr1 regulates intracellular nitrosoglutathione levels [<xref rid="pone.0144025.ref028" ref-type="bibr">28</xref>], an intracellular storage form of nitric oxide, which would impact cardiovascular physiology if the observed decrease in oxidation protects Cbr1 function.</p></sec><sec id="sec017"><title>Mitochondria</title><p>Dysfunctional mitochondria are now recognized as a factor contributing to disease and aging [<xref rid="pone.0144025.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0144025.ref029" ref-type="bibr">29</xref>]. Catalase overexpression improved mitochondrial function in adult mice and attenuated cysteine thiol oxidation of various proteins involved in apoptosis and mitochondrial metabolism.</p><p>Pyruvate dehydrogenase (Pdha1, P35486) is a mitochondrial matrix enzyme that catalyzes oxidative decarboxylation of pyruvate, producing acetyl-CoA that directly feeds into the citric acid cycle. The enzyme plays a fundamental role in cardiac metabolism and adaptation to hypoxic conditions [<xref rid="pone.0144025.ref030" ref-type="bibr">30</xref>]. Our proteomics study identified three cysteine sites with decreases in thiol occupancy (1.3-fold for Cys181; 6.8-fold for Cys218 and Cys222 in Cat Tg <italic>vs</italic>. WT), which would fit with previous reports that found these sites can be S-nitrosylated in the myocardium [<xref rid="pone.0144025.ref031" ref-type="bibr">31</xref>].</p><p>Mammalian multiple mitochondrial dysfunctions syndrome 2 protein (MMDS2; also BolA3, E9Q705) belongs to the BolA-like protein family that has been postulated to act as a reductase for mitochondrial glutaredoxin [<xref rid="pone.0144025.ref032" ref-type="bibr">32</xref>,<xref rid="pone.0144025.ref033" ref-type="bibr">33</xref>]. BolA3 is involved in the assembly of iron-sulfur cluster-containing mitochondrial proteins [<xref rid="pone.0144025.ref033" ref-type="bibr">33</xref>,<xref rid="pone.0144025.ref034" ref-type="bibr">34</xref>] and lipoate synthesis, directly affecting the function of pyruvate dehydrogenase. Fibroblasts deficient in BolA3 exhibit perturbations in the citric acid cycle and mitochondrial electron transport chain. Thus BolA3 would improve mitochondrial respiration and ATP synthesis in Cat Tg mice if the observed decrease in thiol oxidation increases BolA3 activity (Cys47, 2.9-fold decrease in thiol occupancy, Cat Tg <italic>vs</italic>. WT). In our recent publications [<xref rid="pone.0144025.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0144025.ref015" ref-type="bibr">15</xref>], increased cysteine oxidation in iron-sulfur clusters was associated with metabolic heart disease. Particularly, cysteines of the complex II iron-sulfur cluster were oxidized [<xref rid="pone.0144025.ref015" ref-type="bibr">15</xref>], which may contribute to increased oxidant formation in cardiac and age-related diseases.</p><p>Mitochondrial protein serine hydroxymethyltransferase 2 (SHMT2, Q3TFD0, Cys77, 1.4-fold decrease in thiol occupancy, Cat Tg <italic>vs</italic>. WT) is involved in &#8216;one-carbon&#8217; and folate metabolism [<xref rid="pone.0144025.ref035" ref-type="bibr">35</xref>]. These metabolites are essential for nucleotide biosynthesis, numerous methylation reactions and maintaining low homocysteine levels. Increased serum homocysteine is a well-established cardiovascular risk factor and would promote endothelial dysfunction and atherosclerosis if cysteine oxidation leads to enzymatic inhibition of SHMT2.</p><p>Voltage-dependent anion-selective channel proteins (VDAC) [<xref rid="pone.0144025.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0144025.ref037" ref-type="bibr">37</xref>] facilitate passive exchange of ions and transport of ATP, ADP, pyruvate, malate, and other metabolites [<xref rid="pone.0144025.ref038" ref-type="bibr">38</xref>,<xref rid="pone.0144025.ref039" ref-type="bibr">39</xref>]. In conjunction with proteins of the Bcl-2 family, VDACs form the permeability transition pore. During oxidant-mediated apoptosis, the pore opens, facilitating the release of cytochrome C and initiation of additional apoptotic cascades [<xref rid="pone.0144025.ref040" ref-type="bibr">40</xref>,<xref rid="pone.0144025.ref041" ref-type="bibr">41</xref>]. For VDAC1, two cysteines&#8212;Cys127 and Cys232&#8212;are essential for crosslinking high order oligomers upon apoptosis induction [<xref rid="pone.0144025.ref042" ref-type="bibr">42</xref>]. Because, Cys232 is proposed to play a particular role in apoptosis [<xref rid="pone.0144025.ref042" ref-type="bibr">42</xref>], a decrease in reversible cysteine oxidation could indicate suppression of myocyte apoptosis (VDAC1, Q3U6K8, Cys232, 2.1-fold decrease in thiol occupancy; VDAC2, G3UX26, 2.0-fold decreased in thiol occupancy for Cys36, 2.8-fold for Cys65, and 23.6-fold for in Cys199 and Cys216, Cat Tg <italic>vs</italic>. WT) [<xref rid="pone.0144025.ref043" ref-type="bibr">43</xref>]. Attenuating myocyte apoptosis by protecting key mediators from oxidation may preserve the functional integrity of the myocardium.</p></sec><sec id="sec018"><title>Extracellular matrix and contractile proteins</title><p>Myocardial dysfunction may be caused by various factors including dysregulated calcium homeostasis [<xref rid="pone.0144025.ref004" ref-type="bibr">4</xref>] or cross-links of intracellular filamentous and extracellular matrix proteins. Both effects can lead to cardiac muscle stiffening and impairment of relaxation. Catalase overexpression attenuated cysteine thiol oxidation in various cardiac proteins associated with the contractile apparatus, <italic>e</italic>.<italic>g</italic>. titin isoform 2 (Ttn, A2ASS6-2, 2.3-fold decrease in thiol occupancy of Cys23752 in the fibronectin type-III domain, Cat Tg <italic>vs</italic>. WT); cardiac-type myosin-binding protein C (Mybpc3, Q3TF37, 2.5-fold of decrease in thiol occupancy Cys1040 and Cys1041 in the Ig-like C2-type domain, Cat Tg <italic>vs</italic>. WT), and the positive regulator of actin filament polymerization actin-related protein 2/3 complex subunit 2 (Arpc2, Q4FZG5, 1.7-fold decrease in thiol occupancy of Cys96 in Cat Tg <italic>vs</italic>. WT).</p><p>LIM domain-containing cysteine- and glycine-rich proteins (Csrp) are involved in development, cell growth, differentiation [<xref rid="pone.0144025.ref044" ref-type="bibr">44</xref>], and organization of cardiac contractile elements. The LIM domains serve as protein-binding interfaces to mediate subcellular protein localization and function [<xref rid="pone.0144025.ref045" ref-type="bibr">45</xref>]. For example, the first LIM domain and Gly-rich region in Csrp1 is necessary for bundling of actin filaments. Csrp3 is a positive regulator of myogenesis and plays a crucial role in the organization of the Z-line that also functions as a mechanical stretch sensor. In the hearts of Cat Tg mice, these proteins exhibited decreases in thiol occupancy. Thus cysteine oxidation of Csrp proteins may cause structural changes and defects in stretch sensing, leading to remodeling of the myocardium (Csrp1, P97315, 2-fold decrease in thiol occupancy for Cys 58; Csrp3, P50462, 3-fold decrease in thiol occupancy for Cys79 and 1.4-fold for Cys168, Cat Tg vs. WT).</p><p>The latent transforming growth factor &#223;&#8211;binding protein 4 (Ltbp4, Q8K4G1, 2.5-fold decrease in thiol occupancy of Cys1033, Cys1045 and Cys1051, Cat Tg <italic>vs</italic>. WT) is another factor that could be involved in cardiac remodeling. Ltbp4 belongs to the LTBP/fibrillin-family of extracellular matrix (ECM) proteins [<xref rid="pone.0144025.ref046" ref-type="bibr">46</xref>] and forms large latent complexes with transforming growth factor-&#223; (TGF-&#223;) in the ECM. These complexes regulate cell growth and differentiation, immune function, and ECM synthesis and degradation.</p><sec id="sec019"><title>Effects of cysteine oxidation on protein networks</title><p>Pathway analysis (IPA, Ingenuity Systems) was performed with the 82 proteins exhibiting a decrease of &#8805;1.3-fold in reversible thiol oxidation in hearts of Cat Tg <italic>vs</italic>. WT mice. These proteins mainly participate in the &#8220;canonical pathways&#8221; of mitochondrial dysfunction, acute phase response signaling, TCA cycle, and NRF2-mediated oxidative stress response (<xref rid="pone.0144025.s007" ref-type="supplementary-material">S3 Table</xref>). Interestingly, most proteins with &#8805;2-fold decrease in reversible cysteine thiol oxidation were found in metabolic pathways of the mitochondria, suggesting that catalase overexpression may prevent or delay mitochondrial dysfunction in disease and aging. Prevention of damage and apoptosis could be essential to maintaining tissue homeostasis and function, particularly in post-mitotic tissues such as the myocardium which lack significant capacity for tissue regeneration.</p><p>Our pathway analysis illustrates that 66 proteins with altered cysteine thiol oxidation in Cat Tg mice may be associated with catalase through 11 central protein &#8216;nodes&#8217; (<xref rid="pone.0144025.s003" ref-type="supplementary-material">S3 Fig</xref>). Major &#8216;node&#8217; proteins include the tumor suppressor p53 (<xref rid="pone.0144025.g003" ref-type="fig">Fig 3</xref>) and many involved in proteostasis i.e. amyloid precursor protein (APP), small ubiquitin-like modifier 4 (SUMO4) (<xref rid="pone.0144025.g004" ref-type="fig">Fig 4</xref>), and ubiquitin C (UbC) (<xref rid="pone.0144025.g005" ref-type="fig">Fig 5</xref>).</p><fig id="pone.0144025.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0144025.g003</object-id><label>Fig 3</label><caption><title>Pathway analysis-predicted protein networks associated with tumor suppressor p53.</title><p>Legend to network analysis: enzyme (diamond), transmembrane receptor (vertical oval), transcriptional regulator (horizontal oval), phosphatase (triangle), transporter (trapezoid), kinase(triangle), growth factor (square), and other (circle). Relationships: interaction (line), activation (arrow).</p></caption><graphic xlink:href="pone.0144025.g003"/></fig><fig id="pone.0144025.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0144025.g004</object-id><label>Fig 4</label><caption><title>Pathway analysis-predicted protein networks associated with amyloid precursor protein (APP) and small ubiquitin-like modifier SUMO4.</title><p>Legend to network analysis: enzyme (diamond), transmembrane receptor (vertical oval), transcriptional regulator (horizontal oval), phosphatase (triangle), transporter (trapezoid), kinase(triangle), growth factor (square), and other (circle). Relationships: interaction (&#8212;), activation (arrow).</p></caption><graphic xlink:href="pone.0144025.g004"/></fig><fig id="pone.0144025.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0144025.g005</object-id><label>Fig 5</label><caption><title>Pathway analysis-predicted protein networks associated with ubiquitin c (Ubc).</title><p>Legend to network analysis: enzyme (diamond), transmembrane receptor (vertical oval), transcriptional regulator (horizontal oval), phosphatase (triangle), transporter (trapezoid), kinase(triangle), growth factor (square), and other (circle). Relationships: interaction (line), activation (arrow).</p></caption><graphic xlink:href="pone.0144025.g005"/></fig></sec><sec id="sec020"><title>Tumor suppressor p53</title><p>The transcription factor and cell cycle regulator p53 is best known for its role as a tumor suppressor [<xref rid="pone.0144025.ref047" ref-type="bibr">47</xref>]. As a key component in the cellular stress response, p53 is activated by numerous signals, including genotoxic damage, oncogene activation, nutrient or oxygen deprivation, and oxidative stress [<xref rid="pone.0144025.ref048" ref-type="bibr">48</xref>]. Dampened stress response and attenuation of p53-dependent apoptosis probably leads to improved cell survival and could preserve tissue function [<xref rid="pone.0144025.ref049" ref-type="bibr">49</xref>]. In post-mitotic heart tissue, where tumor suppression is not a major concern, p53 likely perpetuates the disease and aging processes.</p><p>Pathway analysis indicated that p53 may function as a central node linking 21 proteins that exhibited differential thiol oxidation in Cat Tg mice (<xref rid="pone.0144025.g003" ref-type="fig">Fig 3</xref>). These proteins include regulatory subunits of serine/threonine-protein phosphatases that modulate oncogenic, insulin, and stress signaling cascades (Ppp2a, P63330, 2.0-fold decrease in thiol occupancy of Cys266; Ppp5c, F7BX26, 1.7-fold decrease in thiol occupancy of Cys76, Cat Tg vs. WT) [<xref rid="pone.0144025.ref050" ref-type="bibr">50</xref>,<xref rid="pone.0144025.ref051" ref-type="bibr">51</xref>]. Ppp2a targets various phosphorylation sites of p53, regulating its stability and transcriptional activity [<xref rid="pone.0144025.ref052" ref-type="bibr">52</xref>,<xref rid="pone.0144025.ref053" ref-type="bibr">53</xref>].</p><p>Another highly expressed p53-regulated cardiac protein with differential cysteine thiol oxidation is N-Myc downstream regulated gene 2 (Ndrg2, Q9QYG0-2, 1.7- and 1.4-fold decreased thiol occupancy of Cys64 and Cys241, respectively, Cat Tg vs. WT) [<xref rid="pone.0144025.ref054" ref-type="bibr">54</xref>&#8211;<xref rid="pone.0144025.ref056" ref-type="bibr">56</xref>]. Ndrg2 is a Myc-repressed gene that regulates cell growth [<xref rid="pone.0144025.ref057" ref-type="bibr">57</xref>], differentiation [<xref rid="pone.0144025.ref054" ref-type="bibr">54</xref>], neurodegeneration [<xref rid="pone.0144025.ref058" ref-type="bibr">58</xref>], and the stress response to oxygen deprivation [<xref rid="pone.0144025.ref059" ref-type="bibr">59</xref>].</p></sec><sec id="sec021"><title>Protein turnover and proteostasis</title><p>Protein homeostasis, or proteostasis, plays an important role in the pathogenesis of many diseases [<xref rid="pone.0144025.ref060" ref-type="bibr">60</xref>]. To counter adverse effects of oxidative stress, cells attempt to repair oxidized proteins by induction of chaperones, or by rapidly channeling damaged proteins into the ubiquitin-proteasome system (UPS) or autophagy for degradation [<xref rid="pone.0144025.ref061" ref-type="bibr">61</xref>,<xref rid="pone.0144025.ref062" ref-type="bibr">62</xref>]. The UPS, however, is the main protein degradation system in the heart, degrading up to 90% of intracellular proteins [<xref rid="pone.0144025.ref063" ref-type="bibr">63</xref>]. Accumulation of oxidized and misfolded proteins is a characteristic of cardiac disease and aging. Proteolysis-resistant proteins, referred to as soluble oligomeric forms of amyloidogenic proteins, exhibit cellular toxicity and may form large insoluble protein aggregates. Applying pathway analysis (Figs <xref rid="pone.0144025.g004" ref-type="fig">4</xref> and <xref rid="pone.0144025.g005" ref-type="fig">5</xref>) indicated various proteins associated with ubiquitin C, small ubiquitin-like modifier (SUMO) 4 or amyloid precursor protein (APP). In addition, isoform-&#223; of heat shock protein (HSP) 105, which could be involved in preventing aggregation of denatured proteins [<xref rid="pone.0144025.ref064" ref-type="bibr">64</xref>,<xref rid="pone.0144025.ref065" ref-type="bibr">65</xref>], was less oxidized in Cat Tg mice (Hsph1, Q61699-2, 1.7-fold decrease in thiol occupancy of Cys167, Cat Tg <italic>vs</italic>. WT), potentially increasing or at least preserving its ability to repair altered proteins. Protein aggregates may also bind and deplete other functionally significant proteins, thus, preventing formation of these aggregates is critical to attenuating cardiac disease and aging.</p></sec></sec><sec id="sec022"><title>Functional effects of catalase overexpression on cardiac mitochondria in Cat Tg mice</title><p>We previously reported that hearts of Cat Tg at 21 months of age were protected from an age-dependent decline in diastolic function and oxidative stress [<xref rid="pone.0144025.ref004" ref-type="bibr">4</xref>]. However, young and middle-aged wild type (WT) and Cat Tg mice revealed no apparent differences in cardiac diastolic function [<xref rid="pone.0144025.ref004" ref-type="bibr">4</xref>]. Because mitochondria can be a major cellular oxidant source [<xref rid="pone.0144025.ref001" ref-type="bibr">1</xref>], we measured mitochondrial oxygen consumption rates, ATP synthesis and H<sub>2</sub>O<sub>2</sub> generation. Mitochondria isolated from adult Cat Tg mouse left ventricles produced significantly less H<sub>2</sub>O<sub>2</sub> from complexes I and II (<xref rid="pone.0144025.g006" ref-type="fig">Fig 6A</xref>) and exhibited increased ATP synthesis rates when utilizing either complex I or II substrates (<xref rid="pone.0144025.g006" ref-type="fig">Fig 6B</xref>), sans significant differences in oxygen consumption rates (<xref rid="pone.0144025.s004" ref-type="supplementary-material">S4 Fig</xref>). This suggests that catalase overexpression could improve mitochondrial function by decreasing ROS generation while concomitantly increasing the efficiency of oxidative phosphorylation. Consistent with the decrease in mitochondrial-derived H<sub>2</sub>O<sub>2</sub> in Cat Tg mice, protein GSH-adducts were globally diminished (<xref rid="pone.0144025.g007" ref-type="fig">Fig 7</xref>), suggesting that reversible cysteine oxidation detected by MS may be predominantly GSH-adducts. Furthermore, these data show that adult mice already exhibit significant changes in reversible protein cysteine thiol oxidation prior to an age-dependent decline in cardiac function. Catalase found in heart tissue has only about 2% of native specific activity exhibited by catalase in the liver. This may explain the heart&#8217;s vulnerability to basal levels of oxidants and the protective effects exhibited by cardiac catalase overexpression [<xref rid="pone.0144025.ref066" ref-type="bibr">66</xref>&#8211;<xref rid="pone.0144025.ref068" ref-type="bibr">68</xref>].</p><fig id="pone.0144025.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0144025.g006</object-id><label>Fig 6</label><caption><title>Cardiac mitochondrial H<sub>2</sub>O<sub>2</sub> production and ATP synthesis rates in Cat Tg mice.</title><p>(A) H<sub>2</sub>O<sub>2</sub> production rates with a complex I substrate (5 mM pyruvate + 5 mM malate) and with a complex II substrate (5 mM succinate and inhibitor of reverse electron transport 2 &#956;M rotenone); (B) Complex I (5 mM pyruvate + 5mM malate) and complex II (5 mM succinate + 2 &#956;M rotenone) substrate-driven ATP synthesis rates. Data represents means &#177; SEM; N = 5&#8211;7; * P&lt;0.05.</p></caption><graphic xlink:href="pone.0144025.g006"/></fig><fig id="pone.0144025.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0144025.g007</object-id><label>Fig 7</label><caption><title>Protein-GSH adduct levels are decreased in catalase transgenic mice.</title><p>Consistent with the decrease in H<sub>2</sub>O<sub>2</sub> formation, protein GSH adducts were decreased in catalase transgenic mouse hearts, as measured by Western blotting analysis using an anti-GSH adduct antibody. GAPDH protein levels in hearts were analyzed by Western blot to ensure equal protein loading.</p></caption><graphic xlink:href="pone.0144025.g007"/></fig></sec></sec><sec sec-type="conclusions" id="sec023"><title>Conclusion</title><p>Our proteomics screen to detect and quantify reversible cysteine thiol oxidation in the myocardium of adult Cat Tg mice identified various alterations that could be pertinent to cardiac disease and aging. Preserved cardiac diastolic function was apparent in the hearts of adult Cat Tg mice, yet we found a significant decrease in global reversible cysteine thiol oxidation, especially of mitochondrial proteins. Thus, we postulate that these changes in cysteine oxidation contribute to the protective effects eventually conferred by catalase overexpression in aged mice [<xref rid="pone.0144025.ref010" ref-type="bibr">10</xref>]. The oxidation status of major biological pathways involved in cardiac disease and aging was affected by catalase overexpression, including cellular stress response, proteostasis, antioxidant systems, apoptosis and myocardial contractile apparatus. We believe that this proteomics study identified novel target proteins that could be important for myocardial aging. Future studies are required, to confirm the functional significance of these protein targets.</p></sec><sec sec-type="supplementary-material" id="sec024"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0144025.s001"><label>S1 Fig</label><caption><title>Multiplexed quantitation of reversible cysteine oxidation in Cat Tg and WT mice.</title><p>(A) TMT-switch labeling strategy. To determine the total available (free and reducible) cysteines, half of each left ventricle was completely reduced and labeled with iodoTMT; to label only reversibly oxidized cysteines, all free cysteines were blocked by IAM during lysis of the other half of the same left ventricles. Then those reversibly oxidized cysteines were reduced by TCEP prior to iodoTMT labeling. Tagged samples were pooled, precipitated to remove excess tag and detergent, and digested with trypsin. Immonopurified tagged peptides were analyzed using a Thermo Q Exactive MS/MS instrument. (B) MS data analysis strategy. From acquired MS/MS spectra, the thiol occupancy was calculated as the ratio between reporter ions used tag reversibly oxidized cysteines and those used to tag total available cysteines. TMT-tagged peptide/protein identification and quantitation from qualified mass spectra was performed in Proteome Discoverer 1.4. Proteins exhibiting changes in reversible cysteine oxidation were further studied for their roles in biological pathways and system biology.</p><p>(TIF)</p></caption><media xlink:href="pone.0144025.s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0144025.s002"><label>S2 Fig</label><caption><title>Validation of TMT-tagged peptides.</title><p>(A) Peptide frequency histogram of the coefficient of variation (CV) for changes in total available cysteine thiols (&#9679;), reversibly oxidized cysteine thiols (&#9633;) and their occupancy (&#8710;). (B) Distribution of TMT-tagged peptides. A total of 2264 peptides with modifications were detected by LC-MS/MS analysis, of which 2125 peptides (94%) contained TMT-labeled cysteine thiols. The recovery of TMT-tagged peptide was greatly improved by removing unreacted TMT tag using protein precipitation prior to incubation with the TMT antibody resin. In summary, 1711 peptides (76%) of the peptides were single-, 348 peptides (15%) double-, and 66 peptides (3%) triple-tagged with TMT. While peptides containing a single cysteine enable quantification on a site-specific basis, peptides with multiple tagged cysteines only allow measuring average oxidation across all affected cysteines. (C) Overlap of TMT-tagged peptides exhibiting changes in total available (in white, left) and reversibly oxidized cysteines (in light grey, right) with CV&#8804;35%. Quantitative proteome analysis requires stepwise selection of qualifying MS data (see <xref rid="sec002" ref-type="sec">methods</xref> for details). In general, reporter ions for total available cysteine thiols (m/z 127 or 129) were more abundant than those for reversibly oxidized cysteine thiols (m/z 126 or 128), resulting in better MS quantification and lower data variability as determined by the coefficient of variation (CV). By selecting a cutoff CV of &#8804;35% for all reporter ion ratios, adequate analytical precision was attained. A total of 658 peptides with quantification values for total available cysteine thiols and 285 peptides with quantification values for reversibly oxidized cysteine thiols qualified for further analysis. The union of both data sets contained 199 overlapping peptides, of which 109 peptides from 82 proteins exhibited &#8805;1.3-fold change in reversible cysteine oxidation. These 82 proteins were submitted for biological pathway analysis.</p><p>(TIF)</p></caption><media xlink:href="pone.0144025.s002.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0144025.s003"><label>S3 Fig</label><caption><title>IPA predicted multiple protein networks associated with oxidative changes caused by catalase overexpression.</title><p>The 11 &#8216;node&#8217; proteins are highlighted in grey. Legend to network analysis: enzyme (diamond), transmembrane receptor (vertical oval), transcriptional regulator (horizontal oval), phosphatase (triangle), transporter (trapezoid), kinase (triangle), growth factor (square), and other (circle). Relationships: interaction (line), activation (arrow).</p><p>(TIF)</p></caption><media xlink:href="pone.0144025.s003.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0144025.s004"><label>S4 Fig</label><caption><title>Cardiac mitochondrial maximal and uncoupled oxygen consumption were similar in both groups.</title><p>
<bold>(</bold>A) Maximal (State III) and uncoupled (oligomycin 2&#956;M) (State IV) complex I substrate-driven oxygen consumption rate; (B) Maximal (State III) and uncoupled (oligomycin 2 &#956;M) (State IV) complex II substrate-driven oxygen consumption rate. Data represents means &#177; SEM; N = 4&#8211;6.</p><p>(TIF)</p></caption><media xlink:href="pone.0144025.s004.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0144025.s005"><label>S1 Table</label><caption><title>Complete list of proteins with a change in thiol oxidation in Cat Tg <italic>vs</italic>. WT.</title><p>Accession number, gene ID, sites of modification and peptide sequences were retrieved from the Uniprot knowledgebase. Fold changes in Cat Tg <italic>vs</italic>. WT, were calculated from ratio of reporter ions for changes in total available cysteine as (m/z 129)/(m/z 127), reversibly oxidized cysteine thiols as (m/z 128)/(m/z 126) and the thiol occupancy as ((m/z 128)/ (m/z 126))/((m/z 129)/(m/z 127)). The thiol occupancy columns indicate percentage thiol occupancy, calculated as (m/z 126)/(m/z 127) for WT, and (m/z 128) /(m/z 129) for Cat Tg, together with The standard error mean (SEM) was calculated from N = 5 biological replicates.</p><p>(DOCX)</p></caption><media xlink:href="pone.0144025.s005.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0144025.s006"><label>S2 Table</label><caption><title>Proteins with a change in thiol occupancy by &gt;2-fold in Cat Tg <italic>vs</italic>. WT mice.</title><p>Accession number, gene ID, sites of modification and peptide sequences were retrieved from the Uniprot knowledgebase. Fold changes in Cat Tg <italic>vs</italic>. WT, were calculated from ratio of reporter ions for changes in total available cysteine as (m/z 129)/(m/z 127), reversibly oxidized cysteine thiols as (m/z 128)/(m/z 126) and the thiol occupancy as ((m/z 128)/ (m/z 126))/((m/z 129)/(m/z 127)). The thiol occupancy columns indicate percentage thiol occupancy, calculated as (m/z 126)/(m/z 127) for WT, and (m/z 128) /(m/z 129) for Cat Tg, together with The standard error mean (SEM) was calculated from N = 5 biological replicates.</p><p>(DOCX)</p></caption><media xlink:href="pone.0144025.s006.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0144025.s007"><label>S3 Table</label><caption><title>Proteins involved in five canonical pathways predicted in IPA, with a change in thiol occupancy by &gt;1.3-fold in Cat Tg <italic>vs</italic>. WT.</title><p>Accession number, gene ID, sites of modification and peptide sequences were retrieved from the Uniprot knowledgebase. Fold changes in Cat Tg <italic>vs</italic>. WT, were calculated from ratio of reporter ions for changes in total available cysteine as (m/z 129)/(m/z 127), reversibly oxidized cysteine thiols as (m/z 128)/(m/z 126) and the thiol occupancy as ((m/z 128)/ (m/z 126))/((m/z 129)/(m/z 127)). The thiol occupancy columns indicate percentage thiol occupancy, calculated as (m/z 126)/(m/z 127) for WT, and (m/z 128) /(m/z 129) for Cat Tg, together with The standard error mean (SEM) was calculated from N = 5 biological replicates.</p><p>(DOCX)</p></caption><media xlink:href="pone.0144025.s007.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>Mark E. McComb and Markus M. Bachschmid are co-senior and co-corresponding authors. The authors would like to thank David R. Pimentel for many helpful discussions and editing of the manuscript. Special thanks to Jiyang Zhang for generating the &#8216;SiteFind&#8217; program. The contents are solely the responsibility of the authors and do not represent the official views of the awarding offices.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>7-kDa MWCO</term><def><p>7-kDa molecular weight cutoff</p></def></def-item><def-item><term>ACN</term><def><p>acetonitrile</p></def></def-item><def-item><term>Cat Tg</term><def><p>catalase overexpressing transgenic mouse</p></def></def-item><def-item><term>CV</term><def><p>coefficient of variation</p></def></def-item><def-item><term>Cys</term><def><p>cysteine</p></def></def-item><def-item><term>DPTA</term><def><p>diethylene triamine pentaacetic acid</p></def></def-item><def-item><term>DTT</term><def><p>dithiothreitol</p></def></def-item><def-item><term>ECM</term><def><p>extracellular matrix</p></def></def-item><def-item><term>FDR</term><def><p>false discovery rate</p></def></def-item><def-item><term>FA</term><def><p>formic acid</p></def></def-item><def-item><term>fwhm</term><def><p>full width at half maximum</p></def></def-item><def-item><term>GSH</term><def><p>glutathione</p></def></def-item><def-item><term>HCD</term><def><p>higher-energy collisional dissociation</p></def></def-item><def-item><term>H<sub>2</sub>O<sub>2</sub></term><def><p>hydrogen peroxide</p></def></def-item><def-item><term>IP</term><def><p>immunoprecipitation</p></def></def-item><def-item><term>IPA</term><def><p>Ingenuity Pathway Analysis</p></def></def-item><def-item><term>IAM</term><def><p>iodoacetamide</p></def></def-item><def-item><term>iodoTMT</term><def><p>iodoacetyl reactive tandem mass tags</p></def></def-item><def-item><term>LV</term><def><p>left ventricle of the heart</p></def></def-item><def-item><term>LC-MS/MS</term><def><p>liquid chromatography-tandem MS</p></def></def-item><def-item><term>MS</term><def><p>mass spectrometry</p></def></def-item><def-item><term>NCE</term><def><p>normalized collision energy</p></def></def-item><def-item><term>PD</term><def><p>Proteome Discoverer</p></def></def-item><def-item><term>SDS-PAGE</term><def><p>sodium dodecyl sulfate polyacrylamide gel electrophoresis</p></def></def-item><def-item><term>TFA</term><def><p>trifluoroacetic acid</p></def></def-item><def-item><term>TBS</term><def><p>Tris-buffered saline</p></def></def-item><def-item><term>TCEP</term><def><p>Tris(2-carboxyethyl)phosphine</p></def></def-item><def-item><term>UPS</term><def><p>ubiquitin-proteasome system</p></def></def-item><def-item><term>WT</term><def><p>wild type</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pone.0144025.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Beckman</surname><given-names>KB</given-names></name>, <name><surname>Ames</surname><given-names>BN</given-names></name>. <article-title>The free radical theory of aging matures</article-title>. <source>Physiol Rev</source>. <year>1998</year>;<volume>78</volume>: <fpage>547</fpage>&#8211;<lpage>81</lpage>.
<?supplied-pmid 9562038?><pub-id pub-id-type="pmid">9562038</pub-id></mixed-citation></ref><ref id="pone.0144025.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Chance</surname><given-names>B</given-names></name>, <name><surname>Sies</surname><given-names>H</given-names></name>, <name><surname>Boveris</surname><given-names>A</given-names></name>. <article-title>Hydroperoxide metabolism in mammalian organs</article-title>. <source>Physiol Rev</source>. <year>1979</year>;<volume>59</volume>: <fpage>527</fpage>&#8211;<lpage>605</lpage>.
<?supplied-pmid 37532?><pub-id pub-id-type="pmid">37532</pub-id></mixed-citation></ref><ref id="pone.0144025.ref003"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Dai</surname><given-names>D-F</given-names></name>, <name><surname>Santana</surname><given-names>LF</given-names></name>, <name><surname>Vermulst</surname><given-names>M</given-names></name>, <name><surname>Tomazela</surname><given-names>DM</given-names></name>, <name><surname>Emond</surname><given-names>MJ</given-names></name>, <name><surname>MacCoss</surname><given-names>MJ</given-names></name>, <etal>et al</etal>
<article-title>Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging</article-title>. <source>Circulation</source>. <year>2009</year>;<volume>119</volume>: <fpage>2789</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.822403</pub-id>
<?supplied-pmid 19451351?><pub-id pub-id-type="pmid">19451351</pub-id></mixed-citation></ref><ref id="pone.0144025.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Qin</surname><given-names>F</given-names></name>, <name><surname>Siwik</surname><given-names>DA</given-names></name>, <name><surname>Lancel</surname><given-names>S</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Kuster</surname><given-names>GM</given-names></name>, <name><surname>Luptak</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>Hydrogen peroxide-mediated SERCA cysteine 674 oxidation contributes to impaired cardiac myocyte relaxation in senescent mouse heart</article-title>. <source>J Am Heart Assoc</source>. <year>2013</year>;<volume>2</volume>: <fpage>e000184</fpage>
<pub-id pub-id-type="doi">10.1161/JAHA.113.000184</pub-id>
<?supplied-pmid 23963753?><pub-id pub-id-type="pmid">23963753</pub-id></mixed-citation></ref><ref id="pone.0144025.ref005"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Wu</surname><given-names>S</given-names></name>, <name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Du</surname><given-names>M</given-names></name>, <name><surname>Li</surname><given-names>S-Y</given-names></name>, <name><surname>Ren</surname><given-names>J</given-names></name>. <article-title>Cardiac-specific overexpression of catalase prolongs lifespan and attenuates ageing-induced cardiomyocyte contractile dysfunction and protein damage</article-title>. <source>Clin Exp Pharmacol Physiol</source>. <volume>34</volume>: <fpage>81</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1681.2007.04540.x</pub-id>
<?supplied-pmid 17201740?><pub-id pub-id-type="pmid">17201740</pub-id></mixed-citation></ref><ref id="pone.0144025.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Kang</surname><given-names>YJ</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Epstein</surname><given-names>PN</given-names></name>. <article-title>Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice</article-title>. <source>J Biol Chem</source>. <year>1996</year>;<volume>271</volume>: <fpage>12610</fpage>&#8211;<lpage>6</lpage>.
<?supplied-pmid 8647872?><pub-id pub-id-type="pmid">8647872</pub-id></mixed-citation></ref><ref id="pone.0144025.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>W&#246;lkart</surname><given-names>G</given-names></name>, <name><surname>Kaber</surname><given-names>G</given-names></name>, <name><surname>Kojda</surname><given-names>G</given-names></name>, <name><surname>Brunner</surname><given-names>F</given-names></name>. <article-title>Role of endogenous hydrogen peroxide in cardiovascular ischaemia/reperfusion function: studies in mouse hearts with catalase-overexpression in the vascular endothelium</article-title>. <source>Pharmacol Res</source>. <year>2006</year>;<volume>54</volume>: <fpage>50</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2006.02.005</pub-id>
<?supplied-pmid 16581262?><pub-id pub-id-type="pmid">16581262</pub-id></mixed-citation></ref><ref id="pone.0144025.ref008"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Li</surname><given-names>G</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Saari</surname><given-names>JT</given-names></name>, <name><surname>Kang</surname><given-names>YJ</given-names></name>. <article-title>Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury</article-title>. <source>Am J Physiol</source>. <year>1997</year>;<volume>273</volume>: <fpage>H1090</fpage>&#8211;<lpage>5</lpage>.
<?supplied-pmid 9321793?><pub-id pub-id-type="pmid">9321793</pub-id></mixed-citation></ref><ref id="pone.0144025.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Turdi</surname><given-names>S</given-names></name>, <name><surname>Han</surname><given-names>X</given-names></name>, <name><surname>Huff</surname><given-names>AF</given-names></name>, <name><surname>Roe</surname><given-names>ND</given-names></name>, <name><surname>Hu</surname><given-names>N</given-names></name>, <name><surname>Gao</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Cardiac-specific overexpression of catalase attenuates lipopolysaccharide-induced myocardial contractile dysfunction: role of autophagy</article-title>. <source>Free Radic Biol Med</source>. <year>2012</year>;<volume>53</volume>: <fpage>1327</fpage>&#8211;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.07.084</pub-id>
<?supplied-pmid 22902401?><pub-id pub-id-type="pmid">22902401</pub-id></mixed-citation></ref><ref id="pone.0144025.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Qin</surname><given-names>F</given-names></name>, <name><surname>Lennon-Edwards</surname><given-names>S</given-names></name>, <name><surname>Lancel</surname><given-names>S</given-names></name>, <name><surname>Biolo</surname><given-names>A</given-names></name>, <name><surname>Siwik</surname><given-names>DA</given-names></name>, <name><surname>Pimentel</surname><given-names>DR</given-names></name>, <etal>et al</etal>
<article-title>Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodeling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice</article-title>. <source>Circ Heart Fail</source>. <year>2010</year>;<volume>3</volume>: <fpage>306</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.109.864785</pub-id>
<?supplied-pmid 20018955?><pub-id pub-id-type="pmid">20018955</pub-id></mixed-citation></ref><ref id="pone.0144025.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Bret&#243;n-Romero</surname><given-names>R</given-names></name>, <name><surname>Lamas</surname><given-names>S</given-names></name>. <article-title>Hydrogen peroxide signaling in vascular endothelial cells</article-title>. <source>Redox Biol</source>. <year>2014</year>;<volume>2</volume>: <fpage>529</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2014.02.005</pub-id>
<?supplied-pmid 24634835?><pub-id pub-id-type="pmid">24634835</pub-id></mixed-citation></ref><ref id="pone.0144025.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Pimentel</surname><given-names>D</given-names></name>, <name><surname>Haeussler</surname><given-names>DJ</given-names></name>, <name><surname>Matsui</surname><given-names>R</given-names></name>, <name><surname>Burgoyne</surname><given-names>JR</given-names></name>, <name><surname>Cohen</surname><given-names>RA</given-names></name>, <name><surname>Bachschmid</surname><given-names>MM</given-names></name>. <article-title>Regulation of cell physiology and pathology by protein S-glutathionylation: lessons learned from the cardiovascular system</article-title>. <source>Antioxid Redox Signal</source>. <year>2012</year>;<volume>16</volume>: <fpage>524</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2011.4336</pub-id>
<?supplied-pmid 22010840?><pub-id pub-id-type="pmid">22010840</pub-id></mixed-citation></ref><ref id="pone.0144025.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Behring</surname><given-names>JB</given-names></name>, <name><surname>Kumar</surname><given-names>V</given-names></name>, <name><surname>Whelan</surname><given-names>SA</given-names></name>, <name><surname>Chauhan</surname><given-names>P</given-names></name>, <name><surname>Siwik</surname><given-names>DA</given-names></name>, <name><surname>Costello</surname><given-names>CE</given-names></name>, <etal>et al</etal>
<article-title>Does reversible cysteine oxidation link the Western diet to cardiac dysfunction?</article-title>
<source>FASEB J</source>. <year>2014</year>;<volume>28</volume>: <fpage>1975</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1096/fj.13-233445</pub-id>
<?supplied-pmid 24469991?><pub-id pub-id-type="pmid">24469991</pub-id></mixed-citation></ref><ref id="pone.0144025.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Liesa</surname><given-names>M</given-names></name>, <name><surname>Luptak</surname><given-names>I</given-names></name>, <name><surname>Qin</surname><given-names>F</given-names></name>, <name><surname>Hyde</surname><given-names>BB</given-names></name>, <name><surname>Sahin</surname><given-names>E</given-names></name>, <name><surname>Siwik</surname><given-names>DA</given-names></name>, <etal>et al</etal>
<article-title>Mitochondrial transporter ATP binding cassette mitochondrial erythroid is a novel gene required for cardiac recovery after ischemia/reperfusion</article-title>. <source>Circulation</source>. <year>2011</year>;<volume>124</volume>: <fpage>806</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.003418</pub-id>
<?supplied-pmid 21788586?><pub-id pub-id-type="pmid">21788586</pub-id></mixed-citation></ref><ref id="pone.0144025.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Sverdlov</surname><given-names>AL</given-names></name>, <name><surname>Elezaby</surname><given-names>A</given-names></name>, <name><surname>Behring</surname><given-names>JB</given-names></name>, <name><surname>Bachschmid</surname><given-names>MM</given-names></name>, <name><surname>Luptak</surname><given-names>I</given-names></name>, <name><surname>Tu</surname><given-names>VH</given-names></name>, <etal>et al</etal>
<article-title>High fat, high sucrose diet causes cardiac mitochondrial dysfunction due in part to oxidative post-translational modification of mitochondrial complex II</article-title>. <source>J Mol Cell Cardiol</source>. <year>2014</year>; <pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.07.018</pub-id>
</mixed-citation></ref><ref id="pone.0144025.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Sahin</surname><given-names>E</given-names></name>, <name><surname>Colla</surname><given-names>S</given-names></name>, <name><surname>Liesa</surname><given-names>M</given-names></name>, <name><surname>Moslehi</surname><given-names>J</given-names></name>, <name><surname>M&#252;ller</surname><given-names>FL</given-names></name>, <name><surname>Guo</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Telomere dysfunction induces metabolic and mitochondrial compromise</article-title>. <source>Nature</source>. <year>2011</year>;<volume>470</volume>: <fpage>359</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1038/nature09787</pub-id>
<?supplied-pmid 21307849?><pub-id pub-id-type="pmid">21307849</pub-id></mixed-citation></ref><ref id="pone.0144025.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Bhatia</surname><given-names>VN</given-names></name>, <name><surname>Perlman</surname><given-names>DH</given-names></name>, <name><surname>Costello</surname><given-names>CE</given-names></name>, <name><surname>McComb</surname><given-names>ME</given-names></name>. <article-title>Software tool for researching annotations of proteins: open-source protein annotation software with data visualization</article-title>. <source>Anal Chem</source>. <year>2009</year>;<volume>81</volume>: <fpage>9819</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1021/ac901335x</pub-id>
<?supplied-pmid 19839595?><pub-id pub-id-type="pmid">19839595</pub-id></mixed-citation></ref><ref id="pone.0144025.ref018"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Spencer</surname><given-names>JL</given-names></name>, <name><surname>Bhatia</surname><given-names>VN</given-names></name>, <name><surname>Whelan</surname><given-names>SA</given-names></name>, <name><surname>Costello</surname><given-names>CE</given-names></name>, <name><surname>McComb</surname><given-names>ME</given-names></name>. <article-title>STRAP PTM: Software Tool for Rapid Annotation and Differential Comparison of Protein Post-Translational Modifications</article-title>. <source>Curr Protoc Bioinformatics</source>. <year>2013</year>;<volume>13</volume>: <fpage>13.22.1</fpage>&#8211;<lpage>13.22.36</lpage>. <pub-id pub-id-type="doi">10.1002/0471250953.bi1322s44</pub-id>
</mixed-citation></ref><ref id="pone.0144025.ref019"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Kashiba-Iwatsuki</surname><given-names>M</given-names></name>, <name><surname>Kitoh</surname><given-names>K</given-names></name>, <name><surname>Kasahara</surname><given-names>E</given-names></name>, <name><surname>Yu</surname><given-names>H</given-names></name>, <name><surname>Nisikawa</surname><given-names>M</given-names></name>, <name><surname>Matsuo</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Ascorbic acid and reducing agents regulate the fates and functions of S-nitrosothiols</article-title>. <source>J Biochem</source>. <year>1997</year>;<volume>122</volume>: <fpage>1208</fpage>&#8211;<lpage>14</lpage>.
<?supplied-pmid 9498567?><pub-id pub-id-type="pmid">9498567</pub-id></mixed-citation></ref><ref id="pone.0144025.ref020"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Charles</surname><given-names>RL</given-names></name>, <name><surname>Schr&#246;der</surname><given-names>E</given-names></name>, <name><surname>May</surname><given-names>G</given-names></name>, <name><surname>Free</surname><given-names>P</given-names></name>, <name><surname>Gaffney</surname><given-names>PRJ</given-names></name>, <name><surname>Wait</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Protein sulfenation as a redox sensor: proteomics studies using a novel biotinylated dimedone analogue</article-title>. <source>Mol Cell Proteomics</source>. <year>2007</year>;<volume>6</volume>: <fpage>1473</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M700065-MCP200</pub-id>
<?supplied-pmid 17569890?><pub-id pub-id-type="pmid">17569890</pub-id></mixed-citation></ref><ref id="pone.0144025.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Cho</surname><given-names>ES</given-names></name>, <name><surname>Johnson</surname><given-names>N</given-names></name>, <name><surname>Snider</surname><given-names>BC</given-names></name>. <article-title>Tissue glutathione as a cyst(e)ine reservoir during cystine depletion in growing rats</article-title>. <source>J Nutr</source>. <year>1984</year>;<volume>114</volume>: <fpage>1853</fpage>&#8211;<lpage>62</lpage>.
<?supplied-pmid 6481481?><pub-id pub-id-type="pmid">6481481</pub-id></mixed-citation></ref><ref id="pone.0144025.ref022"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Ghosh</surname><given-names>S</given-names></name>, <name><surname>Janocha</surname><given-names>AJ</given-names></name>, <name><surname>Aronica</surname><given-names>MA</given-names></name>, <name><surname>Swaidani</surname><given-names>S</given-names></name>, <name><surname>Comhair</surname><given-names>SAA</given-names></name>, <name><surname>Xu</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation</article-title>. <source>J Immunol</source>. <year>2006</year>;<volume>176</volume>: <fpage>5587</fpage>&#8211;<lpage>97</lpage>.
<?supplied-pmid 16622028?><pub-id pub-id-type="pmid">16622028</pub-id></mixed-citation></ref><ref id="pone.0144025.ref023"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Rhee</surname><given-names>SG</given-names></name>, <name><surname>Woo</surname><given-names>HA</given-names></name>, <name><surname>Kil</surname><given-names>IS</given-names></name>, <name><surname>Bae</surname><given-names>SH</given-names></name>. <article-title>Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>: <fpage>4403</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R111.283432</pub-id>
<?supplied-pmid 22147704?><pub-id pub-id-type="pmid">22147704</pub-id></mixed-citation></ref><ref id="pone.0144025.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Ti&#234;n Nguy&#234;n-nhu</surname><given-names>N</given-names></name>, <name><surname>Knoops</surname><given-names>B</given-names></name>. <article-title>Mitochondrial and cytosolic expression of human peroxiredoxin 5 in Saccharomyces cerevisiae protect yeast cells from oxidative stress induced by paraquat</article-title>. <source>FEBS Lett</source>. <year>2003</year>;<volume>544</volume>: <fpage>148</fpage>&#8211;<lpage>52</lpage>.
<?supplied-pmid 12782306?><pub-id pub-id-type="pmid">12782306</pub-id></mixed-citation></ref><ref id="pone.0144025.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Tinguely</surname><given-names>JN</given-names></name>, <name><surname>Wermuth</surname><given-names>B</given-names></name>. <article-title>Identification of the reactive cysteine residue (Cys227) in human carbonyl reductase</article-title>. <source>Eur J Biochem</source>. <year>1999</year>;<volume>260</volume>: <fpage>9</fpage>&#8211;<lpage>14</lpage>.
<?supplied-pmid 10091578?><pub-id pub-id-type="pmid">10091578</pub-id></mixed-citation></ref><ref id="pone.0144025.ref026"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Doorn</surname><given-names>JA</given-names></name>, <name><surname>Maser</surname><given-names>E</given-names></name>, <name><surname>Blum</surname><given-names>A</given-names></name>, <name><surname>Claffey</surname><given-names>DJ</given-names></name>, <name><surname>Petersen</surname><given-names>DR</given-names></name>. <article-title>Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal</article-title>. <source>Biochemistry</source>. <year>2004</year>;<volume>43</volume>: <fpage>13106</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1021/bi049136q</pub-id>
<?supplied-pmid 15476404?><pub-id pub-id-type="pmid">15476404</pub-id></mixed-citation></ref><ref id="pone.0144025.ref027"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Hartmanov&#225;</surname><given-names>T</given-names></name>, <name><surname>Tambor</surname><given-names>V</given-names></name>, <name><surname>Len&#269;o</surname><given-names>J</given-names></name>, <name><surname>Staab-Weijnitz</surname><given-names>CA</given-names></name>, <name><surname>Maser</surname><given-names>E</given-names></name>, <name><surname>Ws&#243;l</surname><given-names>V</given-names></name>. <article-title>S-nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity</article-title>. <source>Chem Biol Interact</source>. <year>2013</year>;<volume>202</volume>: <fpage>136</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2012.12.011</pub-id>
<?supplied-pmid 23295225?><pub-id pub-id-type="pmid">23295225</pub-id></mixed-citation></ref><ref id="pone.0144025.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Bateman</surname><given-names>RL</given-names></name>, <name><surname>Rauh</surname><given-names>D</given-names></name>, <name><surname>Tavshanjian</surname><given-names>B</given-names></name>, <name><surname>Shokat</surname><given-names>KM</given-names></name>. <article-title>Human carbonyl reductase 1 is an S-nitrosoglutathione reductase</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>: <fpage>35756</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M807125200</pub-id>
<?supplied-pmid 18826943?><pub-id pub-id-type="pmid">18826943</pub-id></mixed-citation></ref><ref id="pone.0144025.ref029"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Trifunovic</surname><given-names>A</given-names></name>, <name><surname>Larsson</surname><given-names>N-G</given-names></name>. <article-title>Mitochondrial dysfunction as a cause of ageing</article-title>. <source>J Intern Med</source>. <year>2008</year>;<volume>263</volume>: <fpage>167</fpage>&#8211;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2796.2007.01905.x</pub-id>
<?supplied-pmid 18226094?><pub-id pub-id-type="pmid">18226094</pub-id></mixed-citation></ref><ref id="pone.0144025.ref030"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Tchernyshyov</surname><given-names>I</given-names></name>, <name><surname>Semenza</surname><given-names>GL</given-names></name>, <name><surname>Dang</surname><given-names>C V</given-names></name>. <article-title>HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia</article-title>. <source>Cell Metab</source>. <year>2006</year>;<volume>3</volume>: <fpage>177</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2006.02.002</pub-id>
<?supplied-pmid 16517405?><pub-id pub-id-type="pmid">16517405</pub-id></mixed-citation></ref><ref id="pone.0144025.ref031"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Kohr</surname><given-names>MJ</given-names></name>, <name><surname>Aponte</surname><given-names>AM</given-names></name>, <name><surname>Sun</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>G</given-names></name>, <name><surname>Murphy</surname><given-names>E</given-names></name>, <name><surname>Gucek</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Characterization of potential S-nitrosylation sites in the myocardium</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2011</year>;<volume>300</volume>: <fpage>H1327</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00997.2010</pub-id>
<?supplied-pmid 21278135?><pub-id pub-id-type="pmid">21278135</pub-id></mixed-citation></ref><ref id="pone.0144025.ref032"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Roret</surname><given-names>T</given-names></name>, <name><surname>Tsan</surname><given-names>P</given-names></name>, <name><surname>Couturier</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>B</given-names></name>, <name><surname>Johnson</surname><given-names>MK</given-names></name>, <name><surname>Rouhier</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Structural and spectroscopic insights into BolA-glutaredoxin complexes</article-title>. <source>J Biol Chem</source>. <year>2014</year>;<volume>289</volume>: <fpage>24588</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.572701</pub-id>
<?supplied-pmid 25012657?><pub-id pub-id-type="pmid">25012657</pub-id></mixed-citation></ref><ref id="pone.0144025.ref033"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Huynen</surname><given-names>MA</given-names></name>, <name><surname>Spronk</surname><given-names>CAEM</given-names></name>, <name><surname>Gabald&#243;n</surname><given-names>T</given-names></name>, <name><surname>Snel</surname><given-names>B</given-names></name>. <article-title>Combining data from genomes, Y2H and 3D structure indicates that BolA is a reductase interacting with a glutaredoxin</article-title>. <source>FEBS Lett</source>. <year>2005</year>;<volume>579</volume>: <fpage>591</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2004.11.111</pub-id>
<?supplied-pmid 15670813?><pub-id pub-id-type="pmid">15670813</pub-id></mixed-citation></ref><ref id="pone.0144025.ref034"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Cameron</surname><given-names>JM</given-names></name>, <name><surname>Janer</surname><given-names>A</given-names></name>, <name><surname>Levandovskiy</surname><given-names>V</given-names></name>, <name><surname>Mackay</surname><given-names>N</given-names></name>, <name><surname>Rouault</surname><given-names>TA</given-names></name>, <name><surname>Tong</surname><given-names>W-H</given-names></name>, <etal>et al</etal>
<article-title>Mutations in iron-sulfur cluster scaffold genes NFU1 and BOLA3 cause a fatal deficiency of multiple respiratory chain and 2-oxoacid dehydrogenase enzymes</article-title>. <source>Am J Hum Genet</source>. <year>2011</year>;<volume>89</volume>: <fpage>486</fpage>&#8211;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.08.011</pub-id>
<?supplied-pmid 21944046?><pub-id pub-id-type="pmid">21944046</pub-id></mixed-citation></ref><ref id="pone.0144025.ref035"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Nilsson</surname><given-names>R</given-names></name>, <name><surname>Jain</surname><given-names>M</given-names></name>, <name><surname>Madhusudhan</surname><given-names>N</given-names></name>, <name><surname>Sheppard</surname><given-names>NG</given-names></name>, <name><surname>Strittmatter</surname><given-names>L</given-names></name>, <name><surname>Kampf</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer</article-title>. <source>Nat Commun</source>. <year>2014</year>;<volume>5</volume>: <fpage>3128</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms4128</pub-id>
<?supplied-pmid 24451681?><pub-id pub-id-type="pmid">24451681</pub-id></mixed-citation></ref><ref id="pone.0144025.ref036"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Decker</surname><given-names>W</given-names></name>, <name><surname>Sampson</surname><given-names>MJ</given-names></name>, <name><surname>Craigen</surname><given-names>WJ</given-names></name>, <name><surname>Colombini</surname><given-names>M</given-names></name>. <article-title>Mouse VDAC isoforms expressed in yeast: channel properties and their roles in mitochondrial outer membrane permeability</article-title>. <source>J Membr Biol</source>. <year>1999</year>;<volume>170</volume>: <fpage>89</fpage>&#8211;<lpage>102</lpage>.
<?supplied-pmid 10430654?><pub-id pub-id-type="pmid">10430654</pub-id></mixed-citation></ref><ref id="pone.0144025.ref037"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Young</surname><given-names>MJ</given-names></name>, <name><surname>Bay</surname><given-names>DC</given-names></name>, <name><surname>Hausner</surname><given-names>G</given-names></name>, <name><surname>Court</surname><given-names>DA</given-names></name>. <article-title>The evolutionary history of mitochondrial porins</article-title>. <source>BMC Evol Biol</source>. <year>2007</year>;<volume>7</volume>: <fpage>31</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2148-7-31</pub-id>
<?supplied-pmid 17328803?><pub-id pub-id-type="pmid">17328803</pub-id></mixed-citation></ref><ref id="pone.0144025.ref038"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Shoshan-Barmatz</surname><given-names>V</given-names></name>, <name><surname>Israelson</surname><given-names>A</given-names></name>, <name><surname>Brdiczka</surname><given-names>D</given-names></name>, <name><surname>Sheu</surname><given-names>SS</given-names></name>. <article-title>The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death</article-title>. <source>Curr Pharm Des</source>. <year>2006</year>;<volume>12</volume>: <fpage>2249</fpage>&#8211;<lpage>70</lpage>.
<?supplied-pmid 16787253?><pub-id pub-id-type="pmid">16787253</pub-id></mixed-citation></ref><ref id="pone.0144025.ref039"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Lemasters</surname><given-names>JJ</given-names></name>. <article-title>Modulation of mitochondrial membrane permeability in pathogenesis, autophagy and control of metabolism</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2007</year>;<volume>22</volume>
<issue>Suppl 1</issue>: <fpage>S31</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1746.2006.04643.x</pub-id>
<?supplied-pmid 17567461?><pub-id pub-id-type="pmid">17567461</pub-id></mixed-citation></ref><ref id="pone.0144025.ref040"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Madesh</surname><given-names>M</given-names></name>, <name><surname>Hajn&#243;czky</surname><given-names>G</given-names></name>. <article-title>VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release</article-title>. <source>J Cell Biol</source>. <year>2001</year>;<volume>155</volume>: <fpage>1003</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200105057</pub-id>
<?supplied-pmid 11739410?><pub-id pub-id-type="pmid">11739410</pub-id></mixed-citation></ref><ref id="pone.0144025.ref041"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Petrosillo</surname><given-names>G</given-names></name>, <name><surname>Ruggiero</surname><given-names>FM</given-names></name>, <name><surname>Paradies</surname><given-names>G</given-names></name>. <article-title>Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria</article-title>. <source>FASEB J</source>. <year>2003</year>;<volume>17</volume>: <fpage>2202</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1096/fj.03-0012com</pub-id>
<?supplied-pmid 14656982?><pub-id pub-id-type="pmid">14656982</pub-id></mixed-citation></ref><ref id="pone.0144025.ref042"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Geula</surname><given-names>S</given-names></name>, <name><surname>Naveed</surname><given-names>H</given-names></name>, <name><surname>Liang</surname><given-names>J</given-names></name>, <name><surname>Shoshan-Barmatz</surname><given-names>V</given-names></name>. <article-title>Structure-based analysis of VDAC1 protein: defining oligomer contact sites</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>: <fpage>2179</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.268920</pub-id>
<?supplied-pmid 22117062?><pub-id pub-id-type="pmid">22117062</pub-id></mixed-citation></ref><ref id="pone.0144025.ref043"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Maurya</surname><given-names>SR</given-names></name>, <name><surname>Mahalakshmi</surname><given-names>R</given-names></name>. <article-title>Modulation of human mitochondrial voltage-dependent anion channel 2 (hVDAC-2) structural stability by cysteine-assisted barrel-lipid interactions</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>: <fpage>25584</fpage>&#8211;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.493692</pub-id>
<?supplied-pmid 23873934?><pub-id pub-id-type="pmid">23873934</pub-id></mixed-citation></ref><ref id="pone.0144025.ref044"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Kontaxis</surname><given-names>G</given-names></name>, <name><surname>Konrat</surname><given-names>R</given-names></name>, <name><surname>Kr&#228;utler</surname><given-names>B</given-names></name>, <name><surname>Weiskirchen</surname><given-names>R</given-names></name>, <name><surname>Bister</surname><given-names>K</given-names></name>. <article-title>Structure and intramodular dynamics of the amino-terminal LIM domain from quail cysteine- and glycine-rich protein CRP2</article-title>. <source>Biochemistry</source>. <year>1998</year>;<volume>37</volume>: <fpage>7127</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1021/bi973055v</pub-id>
<?supplied-pmid 9585524?><pub-id pub-id-type="pmid">9585524</pub-id></mixed-citation></ref><ref id="pone.0144025.ref045"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Schmeichel</surname><given-names>KL</given-names></name>, <name><surname>Beckerle</surname><given-names>MC</given-names></name>. <article-title>The LIM domain is a modular protein-binding interface</article-title>. <source>Cell</source>. <year>1994</year>;<volume>79</volume>: <fpage>211</fpage>&#8211;<lpage>9</lpage>.
<?supplied-pmid 7954790?><pub-id pub-id-type="pmid">7954790</pub-id></mixed-citation></ref><ref id="pone.0144025.ref046"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Okl&#252;</surname><given-names>R</given-names></name>, <name><surname>Hesketh</surname><given-names>R</given-names></name>. <article-title>The latent transforming growth factor beta binding protein (LTBP) family</article-title>. <source>Biochem J</source>. <year>2000</year>;<volume>352</volume>
<issue>Pt 3</issue>: <fpage>601</fpage>&#8211;<lpage>10</lpage>.
<?supplied-pmid 11104663?><pub-id pub-id-type="pmid">11104663</pub-id></mixed-citation></ref><ref id="pone.0144025.ref047"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Vousden</surname><given-names>KH</given-names></name>, <name><surname>Prives</surname><given-names>C</given-names></name>. <article-title>Blinded by the Light: The Growing Complexity of p53</article-title>. <source>Cell</source>. <year>2009</year>;<volume>137</volume>: <fpage>413</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.04.037</pub-id>
<?supplied-pmid 19410540?><pub-id pub-id-type="pmid">19410540</pub-id></mixed-citation></ref><ref id="pone.0144025.ref048"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Horn</surname><given-names>HF</given-names></name>, <name><surname>Vousden</surname><given-names>KH</given-names></name>. <article-title>Coping with stress: multiple ways to activate p53</article-title>. <source>Oncogene</source>. <year>2007</year>;<volume>26</volume>: <fpage>1306</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1210263</pub-id>
<?supplied-pmid 17322916?><pub-id pub-id-type="pmid">17322916</pub-id></mixed-citation></ref><ref id="pone.0144025.ref049"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Hasty</surname><given-names>P</given-names></name>, <name><surname>Christy</surname><given-names>BA</given-names></name>. <article-title>p53 as an intervention target for cancer and aging</article-title>. <source>Pathobiol Aging Age Relat Dis</source>. <year>2013</year>;<volume>3</volume>
<pub-id pub-id-type="doi">10.3402/pba.v3i0.22702</pub-id>
</mixed-citation></ref><ref id="pone.0144025.ref050"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Hinds</surname><given-names>TD</given-names></name>, <name><surname>S&#225;nchez</surname><given-names>ER</given-names></name>. <article-title>Protein phosphatase 5</article-title>. <source>Int J Biochem Cell Biol</source>. <year>2008</year>;<volume>40</volume>: <fpage>2358</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2007.08.010</pub-id>
<?supplied-pmid 17951098?><pub-id pub-id-type="pmid">17951098</pub-id></mixed-citation></ref><ref id="pone.0144025.ref051"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Janssens</surname><given-names>V</given-names></name>, <name><surname>Goris</surname><given-names>J</given-names></name>. <article-title>Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling</article-title>. <source>Biochem J</source>. <year>2001</year>;<volume>353</volume>: <fpage>417</fpage>&#8211;<lpage>39</lpage>.
<?supplied-pmid 11171037?><pub-id pub-id-type="pmid">11171037</pub-id></mixed-citation></ref><ref id="pone.0144025.ref052"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Dohoney</surname><given-names>KM</given-names></name>, <name><surname>Guillerm</surname><given-names>C</given-names></name>, <name><surname>Whiteford</surname><given-names>C</given-names></name>, <name><surname>Elbi</surname><given-names>C</given-names></name>, <name><surname>Lambert</surname><given-names>PF</given-names></name>, <name><surname>Hager</surname><given-names>GL</given-names></name>, <etal>et al</etal>
<article-title>Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage</article-title>. <source>Oncogene</source>. <year>2004</year>;<volume>23</volume>: <fpage>49</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1207005</pub-id>
<?supplied-pmid 14712210?><pub-id pub-id-type="pmid">14712210</pub-id></mixed-citation></ref><ref id="pone.0144025.ref053"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Peng</surname><given-names>A</given-names></name>, <name><surname>Maller</surname><given-names>JL</given-names></name>. <article-title>Serine/threonine phosphatases in the DNA damage response and cancer</article-title>. <source>Oncogene</source>. <year>2010</year>;<volume>29</volume>: <fpage>5977</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2010.371</pub-id>
<?supplied-pmid 20838380?><pub-id pub-id-type="pmid">20838380</pub-id></mixed-citation></ref><ref id="pone.0144025.ref054"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Hu</surname><given-names>X-L</given-names></name>, <name><surname>Liu</surname><given-names>X-P</given-names></name>, <name><surname>Deng</surname><given-names>Y-C</given-names></name>, <name><surname>Lin</surname><given-names>S-X</given-names></name>, <name><surname>Wu</surname><given-names>L</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Expression analysis of the NDRG2 gene in mouse embryonic and adult tissues</article-title>. <source>Cell Tissue Res</source>. <year>2006</year>;<volume>325</volume>: <fpage>67</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-005-0137-5</pub-id>
<?supplied-pmid 16520977?><pub-id pub-id-type="pmid">16520977</pub-id></mixed-citation></ref><ref id="pone.0144025.ref055"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>N</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Yang</surname><given-names>Q</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis</article-title>. <source>Nucleic Acids Res</source>. <year>2008</year>;<volume>36</volume>: <fpage>5335</fpage>&#8211;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn504</pub-id>
<?supplied-pmid 18689861?><pub-id pub-id-type="pmid">18689861</pub-id></mixed-citation></ref><ref id="pone.0144025.ref056"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Ma</surname><given-names>J-J</given-names></name>, <name><surname>Liao</surname><given-names>C-G</given-names></name>, <name><surname>Jiang</surname><given-names>X</given-names></name>, <name><surname>Zhao</surname><given-names>H-D</given-names></name>, <name><surname>Yao</surname><given-names>L-B</given-names></name>, <name><surname>Bao</surname><given-names>T-Y</given-names></name>. <article-title>NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498</article-title>. <source>J Exp Clin Cancer Res</source>. <year>2010</year>;<volume>29</volume>: <fpage>103</fpage>
<pub-id pub-id-type="doi">10.1186/1756-9966-29-103</pub-id>
<?supplied-pmid 20673333?><pub-id pub-id-type="pmid">20673333</pub-id></mixed-citation></ref><ref id="pone.0144025.ref057"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Takahashi</surname><given-names>K</given-names></name>, <name><surname>Yamada</surname><given-names>M</given-names></name>, <name><surname>Ohata</surname><given-names>H</given-names></name>, <name><surname>Honda</surname><given-names>K</given-names></name>, <name><surname>Yamada</surname><given-names>M</given-names></name>. <article-title>Ndrg2 promotes neurite outgrowth of NGF-differentiated PC12 cells</article-title>. <source>Neurosci Lett</source>. <year>2005</year>;<volume>388</volume>: <fpage>157</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2005.06.055</pub-id>
<?supplied-pmid 16039777?><pub-id pub-id-type="pmid">16039777</pub-id></mixed-citation></ref><ref id="pone.0144025.ref058"><label>58</label><mixed-citation publication-type="journal">
<name><surname>Mitchelmore</surname><given-names>C</given-names></name>, <name><surname>B&#252;chmann-M&#248;ller</surname><given-names>S</given-names></name>, <name><surname>Rask</surname><given-names>L</given-names></name>, <name><surname>West</surname><given-names>MJ</given-names></name>, <name><surname>Troncoso</surname><given-names>JC</given-names></name>, <name><surname>Jensen</surname><given-names>NA</given-names></name>. <article-title>NDRG2: a novel Alzheimer&#8217;s disease associated protein</article-title>. <source>Neurobiol Dis</source>. <year>2004</year>;<volume>16</volume>: <fpage>48</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2004.01.003</pub-id>
<?supplied-pmid 15207261?><pub-id pub-id-type="pmid">15207261</pub-id></mixed-citation></ref><ref id="pone.0144025.ref059"><label>59</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Liu</surname><given-names>N</given-names></name>, <name><surname>Yao</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>F</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Deng</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells</article-title>. <source>Cell Physiol Biochem</source>. <year>2008</year>;<volume>21</volume>: <fpage>239</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1159/000113765</pub-id>
<?supplied-pmid 18209490?><pub-id pub-id-type="pmid">18209490</pub-id></mixed-citation></ref><ref id="pone.0144025.ref060"><label>60</label><mixed-citation publication-type="journal">
<name><surname>Sandri</surname><given-names>M</given-names></name>, <name><surname>Robbins</surname><given-names>J</given-names></name>. <article-title>Proteotoxicity: an underappreciated pathology in cardiac disease</article-title>. <source>J Mol Cell Cardiol</source>. <year>2014</year>;<volume>71</volume>: <fpage>3</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.12.015</pub-id>
<?supplied-pmid 24380730?><pub-id pub-id-type="pmid">24380730</pub-id></mixed-citation></ref><ref id="pone.0144025.ref061"><label>61</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Robbins</surname><given-names>J</given-names></name>. <article-title>Proteasomal and lysosomal protein degradation and heart disease</article-title>. <source>J Mol Cell Cardiol</source>. <year>2014</year>;<volume>71</volume>: <fpage>16</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.11.006</pub-id>
<?supplied-pmid 24239609?><pub-id pub-id-type="pmid">24239609</pub-id></mixed-citation></ref><ref id="pone.0144025.ref062"><label>62</label><mixed-citation publication-type="journal">
<name><surname>Cohen</surname><given-names>FE</given-names></name>, <name><surname>Kelly</surname><given-names>JW</given-names></name>. <article-title>Therapeutic approaches to protein-misfolding diseases</article-title>. <source>Nature</source>. <year>2003</year>;<volume>426</volume>: <fpage>905</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/nature02265</pub-id>
<?supplied-pmid 14685252?><pub-id pub-id-type="pmid">14685252</pub-id></mixed-citation></ref><ref id="pone.0144025.ref063"><label>63</label><mixed-citation publication-type="journal">
<name><surname>Cui</surname><given-names>Z</given-names></name>, <name><surname>Scruggs</surname><given-names>SB</given-names></name>, <name><surname>Gilda</surname><given-names>JE</given-names></name>, <name><surname>Ping</surname><given-names>P</given-names></name>, <name><surname>Gomes</surname><given-names>A V</given-names></name>. <article-title>Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond</article-title>. <source>J Mol Cell Cardiol</source>. <year>2014</year>;<volume>71</volume>: <fpage>32</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.10.008</pub-id>
<?supplied-pmid 24140722?><pub-id pub-id-type="pmid">24140722</pub-id></mixed-citation></ref><ref id="pone.0144025.ref064"><label>64</label><mixed-citation publication-type="journal">
<name><surname>Xu</surname><given-names>G</given-names></name>, <name><surname>Paige</surname><given-names>JS</given-names></name>, <name><surname>Jaffrey</surname><given-names>SR</given-names></name>. <article-title>Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling</article-title>. <source>Nat Biotechnol</source>. <year>2010</year>;<volume>28</volume>: <fpage>868</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1654</pub-id>
<?supplied-pmid 20639865?><pub-id pub-id-type="pmid">20639865</pub-id></mixed-citation></ref><ref id="pone.0144025.ref065"><label>65</label><mixed-citation publication-type="journal">
<name><surname>Wakatsuki</surname><given-names>T</given-names></name>, <name><surname>Hatayama</surname><given-names>T</given-names></name>. <article-title>Characteristic expression of 105-kDa heat shock protein (HSP105) in various tissues of nonstressed and heat-stressed rats</article-title>. <source>Biol Pharm Bull</source>. <year>1998</year>;<volume>21</volume>: <fpage>905</fpage>&#8211;<lpage>10</lpage>.
<?supplied-pmid 9781836?><pub-id pub-id-type="pmid">9781836</pub-id></mixed-citation></ref><ref id="pone.0144025.ref066"><label>66</label><mixed-citation publication-type="journal">
<name><surname>Doroshow</surname><given-names>JH</given-names></name>, <name><surname>Locker</surname><given-names>GY</given-names></name>, <name><surname>Myers</surname><given-names>CE</given-names></name>. <article-title>Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin</article-title>. <source>J Clin Invest</source>. <year>1980</year>;<volume>65</volume>: <fpage>128</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1172/JCI109642</pub-id>
<?supplied-pmid 7350193?><pub-id pub-id-type="pmid">7350193</pub-id></mixed-citation></ref><ref id="pone.0144025.ref067"><label>67</label><mixed-citation publication-type="journal">
<name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Saari</surname><given-names>JT</given-names></name>, <name><surname>Kang</surname><given-names>YJ</given-names></name>. <article-title>Weak antioxidant defenses make the heart a target for damage in copper-deficient rats</article-title>. <source>Free Radic Biol Med</source>. <year>1994</year>;<volume>17</volume>: <fpage>529</fpage>&#8211;<lpage>36</lpage>.
<?supplied-pmid 7867969?><pub-id pub-id-type="pmid">7867969</pub-id></mixed-citation></ref><ref id="pone.0144025.ref068"><label>68</label><mixed-citation publication-type="book">
<name><surname>Ishikawa</surname><given-names>T</given-names></name>, <name><surname>Akerboom</surname><given-names>TPM</given-names></name>, <name><surname>Sies</surname><given-names>H</given-names></name>. <source>Target Organ Toxicity, Volume 1</source>. <name><surname>Cohen</surname></name>, editor. <publisher-loc>Boca Raton</publisher-loc>: <publisher-name>CRC Press, Inc.</publisher-name>; <year>1986</year>.</mixed-citation></ref></ref-list></back></article>